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ABSTRACT OF THE DISSERTATION
Assessing Functional Deficits at Optic Neuritis Onset in EAE Mice Using Manganese-Enhanced
MRI (MEMRI) and Diffusion fMRI
by
Tsen-Hsuan Lin
Doctor of Philosophy in Physics
Washington University in St. Louis, 2013
Professor Mark S. Conradi, Chair
Professor Shen-Kwei Song, Co-Chair

Optic neuritis (ON) is frequently a first sign of multiple sclerosis (MS), which is an
inflammatory demyelinative disease of the central nerve system (CNS), including brain, optic
nerve, and spinal cord. Investigating ON provides an approach to improve MS diagnosis and
treatment monitoring. Experimental autoimmune encephalomyelitis (EAE) is a widely used
animal model of MS and exhibits pathologies similar to the human disease. Magnetic resonance
imaging (MRI) is a non-invasive tool to detect disease progress and as a standard diagnose
procedure for MS in the clinic. In biological samples, the hydrogen nuclei are used to produce
the MR signal due to its abundance in water and fat. As a result of tissue microstructural
differences, 1H nuclei exhibit tissue-specific and pathology-specific relaxation and diffusion
properties, which are reflected in the resulting MR image contrast. Therefore, the pathologies of
MS, such as inflammation, demyelination, and axonal injury can be detected using different MRrelated tools, including T1- and T2-weighted imaging, diffusion-weighted imaging, and diffusion
tensor imaging, and so on. Importantly, direct non-invasive assessment of functional deficits
could be important for understanding pathology mechanisms or provide a useful bio-index to
xiii

validate treatment strategies. In this dissertation, manganese-enhanced MRI (MEMRI) and
diffusion fMRI were introduced to explore the functional deficits, including axonal transport
disruption and axon-activity dysfunction, at optic neuritis onset in EAE mice.
.

xiv

Chapter 1
Introduction
1.1 Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating disease that mainly affects the
central nervous system (CNS) such as brain, optic nerve and spinal cord (Fig. 1 – 1), usually
diagnosed in young adults [1, 2]. Main symptoms include impaired vision, extreme fatigue,
spasms, and paralysis of a variety of muscle systems [3]. Hallmarks of MS include focal
inflammatory infiltration, demyelination, oligodendrocyte depletion, and axonal degeneration
[4]. Around 85% of all MS cases initially develop relapsing-remitting MS (RR-MS, Fig. 1 – 2A),
characterized by episodes of neurological disability and return to baseline. Approximately 50%
of RR-MS patients, so-called secondary progressive MS (SP-MS, Fig. 1 – 2B), show relapses but
clinical disability worsens over time. While people with SP-MS experience fewer relapses, the
disability worsens and symptoms might become more severe. There is another 10% of all MS
cases called primary progressive MS (PP-MS, Fig. 1 – 2C), chracterized by steadily worsening
clinical disability. The final 5% of all MS cases, called progressive relapsing MS (PR-MS, Fig. 1
– 2D), is characterized by steady worsening of disability along with occasional relapses [5, 6].

1

Figure 1 – 1 Disease process of MS is believed to start when lymphocytes cross the blood-brain
barrier (BBB) and attack the myelin sheaths in CNS. Ultimately, it leads to axonal
injury/degeneration.

2

Figure 1 – 2 Types of MS (left to right; top to bottom): relapsing-remitting (A), secondary
progressive (B), primary progressive and (C) progressive relapsing (D)

3

1.2 Disease Process of Multiple Sclerosis
It is believed that most MS starts with increased migration of lymphocytes across the
blood-brain barrier (BBB) [4]. The lymphocyte-derived inflammation causes oligodendrocyteassociated demyelination which then blocks or slows propagation of electrical signals by whitematter axons (Fig. 1 – 3). In demyelinated axons, increased sodium channels redistribute
homogeneously along axons to maintain conduction propagation, therefore, energy demand
should be higher than usual to support extra regulation (Fig. 1 – 4). Importantly, mitochondria
provide energy in form of ATP in CNS to maintain regular function, including conduction
propagation and transport of proteins and organelles [7, 8]. However, due to acute inflammation,
activated microglia and macrophages produce nitric oxide (NO), which can act to inhibit
mitochondrial energy production, leading to diminished ATP. Therefore, this leads to
dysfunction of energy-consuming Na+/K+ ATPase pump and Na+/Ca2+ exchanger and eventually
Ca2+ overload, which is directly associated with mitochondrial dysfunction. One consequence of
this compromised cellular energetic status is a dysfunction of electrical signal propagation and
axonal transport. Another serious consequence is a disruption of axonal protein and organelle
transport along the length of the axons, required to maintain regular function, which further
contributes to mitochondrial failure, leading to axonal injury and degeneration, [9, 10, 2, 11-15].
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Figure 1 – 3 Electrical signal (action potential) propagation in myelinated and demyelinated
axons. In MS, activated microglial cells attack myelin sheaths in CNS and lead to demyelination.
The left-hand side of the figure shows fast signal propagation in myelinated axon. The
membrane electrical disturbances jump between consecutive nodes of Ranvier. The right-hand
side shows that electrical signal propagation in demyelinated axon is slowed due to non-saltatory
membrane conduction (flat arrows).
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Figure 1 – 4 Sodium channels are increased and redistributed along demyelinated axons to main
electrical signal (action potential) propagation.
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1.3 Optic Neuritis of Multiple Sclerosis
Optic neuritis is an inflammatory disorder of the optic nerve and is the first sign of MS in
66% of cases (Fig. 1 – 5). Typically, MS patients with optic neuritis have sudden mono-ocular
visual loss and/or pain [16, 17]. The ten- and fifteen-year risk of developing clinical MS
following a single episode of optic neuritis is 38% and 50%, respectively [16, 18]. Hence,
investigating the etiology and treatment of optic neuritis might be crucial to reduce later
development of MS and long-term disability due to the significant relationship between MS and
optic neuritis [19]. In general, patients are examined by vision tests (i.e. visual acuity, color
vision, etc.) and diagnosis is confirmed with visual evoke potential (VEP), magnetic resonance
imaging (MRI) and optical coherence tomography (OCT) [20]. VEP tests are recordings of the
nervous system’s electrical response to visual stimulation and might highlight demyelination
which delays or blocks electrical potential propagation [21]. MRI could provide a non-invasive
means to diagnose the lesion in CNS [18, 22]. OCT is a non-invasive measurement using
infrared light to reflect retinal thickness, which is associated with axonal and neuronal
degeneration [23, 24].

7

Figure 1 – 5 Visual signal is relayed from from retinal ganglion cell axons of the optic nerve via
synaptic terminalsto the lateral geniculate nucleus (LGN) and superior colliculus (SC).
Demyelination cancause signal propagation blockage and lead to axonal injury.
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1.4 Animal Model of Multiple Sclerosis
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of MS
and can be induced in several species, including mice, rats, non-human primates, and so on. EAE
is induced by immunization with myelin antigens (active induction) such as myelin
oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and myelin proteolipid
protein (PLP) or via adoptive transfer of myelin-reactive T cells (passive induction) [5, 25, 26].
Many of the immune mediators responsible for EAE pathologies have been shown to play a role
in MS, but there are differences between EAE and MS: the auto-antigen against which the
immune response is directed is known in EAE, while the etiology of MS is unknown. However,
EAE models have greatly advanced our understanding of T-cell mediated neuroinflammation.
For example, heterogeneity of disease is an important feature of both EAE and MS [25]. MOGspecific EAE in rodents has been shown to include the development of optic neuritis during its
course [27-29] and provides an appropriate model to investigate optic neuritis of MS.
1.5 Mouse Visual System and Visual Acuity
The mouse visual system has become one of the primary models for the study of the
human visual system. The mouse eye is remarkably similar in structure to the human eye and
shares similar cell types and structural features. Therefore, studies in the mouse models might
lead to a better understanding of the mechanism of human disease [30]. Indeed, the mouse visual
system has been reported to show functional response similar to the human visual system [31].
The visual pathway starts from retinal ganglion cells (inner layer of retina), and connects to the
optic nerve. After the optic chiasm, 95% of optic nerve axons project to the contralateral optic
tract, lateral geniculate nuclei (LGN), and superior colliculus (SC) [32] (Fig. 1 – 6).
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To determine if EAE mouse developed optic neuritis, rapid and reproducible behavioral
assessment of visual-tracking was introduced using Virtual Optometry System (Optomotry,
Cerebral Mechanics, Inc., Canada) to reflect visual system integrity [33, 34] (Fig. 1 – 7). Briefly,
virtual rotating columns were projected on the LCD monitors with different spatial frequencies
in cycles/degree (c/d). The mouse head movement in response to the virtual column rotations
was noted. The spatial frequency was incremented from 0.1 c/d with step size of 0.05 c/d until
the mouse stopped responding. The VA was defined as the highest spatial frequency of virtual
rotating columns to which the mouse was able to respond. We have previously reported that
normal VA of C57BL/6 was 0.38 ± 0.03 c/d (mean ± S.D., n=30) and defined VA ≤ 0.25 c/d as
the onset of acute ON for EAE mice [35]. In Chapter 3 and 4, after immunization, VA of each
eye was evaluated daily. MRI was performed on mice with VA ≤ 0.25 c/d, the operational
definition of ON.
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Figure 1 – 6 Visual system consists of retina, optic nerve, optic chiasm, optic tract, lateral
geniculate nucleus (LGN), and superior colliculus (SC). Most (~95%) optic nerve after optic
chiasm corresponds to contralateral LGN and SC (A). After intravitreal Mn2+ injection, it goes
from ipsilateral retina and optic nerve to contralateral LGN and SC (seen details in Chapter 2 and
3). The real mouse optic nerve and optic chiasm are shown the same structure as A.
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Figure 1 – 7 Optokinetic response (OKR) reflects mouse visual acuity. The testing apparatus
was comprised by four LCD monitors (faced inward) with a camera at the top (A). Mouse was
placed in the testing box surrounding with LCDs. Moving bar graphs were provided on the
screens with different spatial frequencies (cycle/degree) (B and C); therefore, mouse can see
thick (lower spatial frequency) or thin (higher spatial frequency) bar graphs. Direction of
moving bar graphs can move either clockwise or counterclockwise to test specific left and right
eye. Operator can track movement of mouse head to determine if mouse responded or not. (Seen
Section 1.6 for details protocol of operation)
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1.6 Magnetic Resonance Imaging as a Non-invasive Bio-marker
Magnetic resonance imaging (MRI) has been a non-invasive approach to the diagnosis of
MS since the first MR images were acquired in MS patients in the early 1980s [36]. MRI now
serves as one of the standard diagnostic approaches for MS. Therefore, it is a promising tool in
assessment of optic neuritis in MS and EAE [1, 37-42]. The inflammation induced
morphological changes in CNS, including BBB break-down, inflammation, demyelination,
axonal injury or degeneration, are validated by gadolinium contrast enhancement image,
manganese-enhanced MRI (MEMRI), T1- and T2-weighted image, diffusion-weighted imaging
(DWI), and diffusion-tensor imaging (DTI). According to these approaches, morphological
features of optic neuritis in MS and EAE are further understood. However, these metrics cannot
directly assess the functional deficits in optic nerve/white matter in MS and EAE. Since
functional deficits might precede morphological changes, investigating functional deficits should
shed light on treatment strategies for optic neuritis that could further prevention of MS. MRI
might provide an in vivo non-invasive means to ‘monitor’ real-time functional processes. We
believe that regular axonal activity, including axonal transport (Fig. 1 – 8) and electrical signal
propagation (Fig. 1 – 3), can be detected by MRI. The following sections will introduce some
important principles of NMR/MRI and show how we take advantage of these properties to reflect
biological function.
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Figure 1 – 8 Axonal transport is crucial to maintain regular function. Motor proteins can move
along microtubules, the cytoskeleton of axon, within axons to deliver proteins and organelles in
either anterograde or retrograde direction.
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1.7 Nuclear Magnetic Resonance and Magnetic Resonance Imaging
MRI is an advanced application of nuclear magnetic resonance (NMR). NMR began in
1946 with two independent but simultaneous groups led by Purcell [43] and Bloch [44],
respectively. The key property of NMR-active nuclei is that they possess spin or intrinsic spin
angular momentum. However, not all nuclei exhibit spin. Specific isotopes fall into one of three
groups of spin values, zero, integral, and half-integral. Only integral spin value with an even
atomic weight and an odd atomic number (e.g. 2H) and half-integral spin value with an odd
atomic weight (e.g. 1H, 23Na, and 31P, etc.) can be detected in NMR. The 1H nucleus is the most
commonly-used nuclei for use in MRI signals. It has a spin of ½ and is the most abundant
isotope of hydrogen.
Water molecules, which constitute two third of human/animal body weight, consist of two
hydrogens and one oxygen atom. Thus water protons account for the bulk of the 1H MRI signal
in biological samples. In the absence of a magnetic field, protons with ½ spin equally distribute
between two energy states and thus cancel their collective magnetic effect. In the magnet with
constant magnetic field B0 ̂ , at equilibrium, the fraction of spins that are oriented parallel to the
direction of B0 is slightly greater than those that are anti-parallel to B0. The equilibrium
population of spin states is by Boltzmann statistics (Eq. 1.1).
(1.1)
where Nm is the fraction of particle population in each state, k is Boltzmann constant, 1.381 ×1023

JK-1, and T is the absolute temperature in Kelvin. This unequal population of spin-states

produces a non-zero net magnetization (vector sum of spin-up and spin-down within the
ensemble).
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The corresponding Hamiltonian of the interaction between the spins and B0 field is shown
in Eq. (1.2)
(1.2)
where H is the Hamiltonian operator, Ψm is an eigenfunction, Iz is an angular momentum
operator, γ is gyromagnetic ratio, m is its spin quantum number, B0 is the main magnetic field
strength, һ is Planck’s constant, 6.626 × 10-34 J·s (ћ is һ divided by 2π), and –mћγB0 is the
corresponding eigenvalue. The energy gap between two states is shown in Eq. (1.3) (Fig. 1 – 9)
(1.3)
(1.4)
A time-varying (varying with frequency ν0 = 0/2), applied perpendicular to B0 magnetic field,
and typically denoted as B1 can induce transitions between the two spin states. The resonance is
known as resonance frequency or absorption frequency, which is associated with γ and B0.
For each proton (microscopic view), the angular momentum is quantized. However, for a
bulk sample of magnetic dipoles (macroscopic view), the interaction of the net magnetization
with applied magnetic fields (B0 and/or B1) is conveniently treated using classical mechanics [46]
(Fig. 1 – 10). This macroscopic view ignores quantum effects due to the small order of ћ [45].
In this classical treatment, the net magnetization precesses in the B0 field with a frequency that is
the same as the absorption frequency, called the Larmor frequency.
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Figure 1 – 9 Nuclei that possess spin align themselves to the corresponding energy state in
magnetic field, so-called Zeeman Effect. The spins are separated into two groups -1/2 (antiparallel) and +1/2 (parallel) by magnetic field. Energy gap can correspond to specific resonance
frequency, so-called Larmor frequency.
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Figure 1 – 10 For macroscopic view, net magnetization is the vector to represent the
combination effects of total spins
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1.7.1 T1 and T2 Relaxation
Magnetization in magnetic field experiences a torque, which is the rate of change of
angular momentum (analogous to Newton’s first law that force is the rate of change of
momentum). Their relationships could be presented as a motion equation like Eq. (1.5) and (1.6)
(in rotating frame)
(1.5)

(1.6)
where L = Iω0, µ = γ L, N is a torque, µ is a dipole moment, B is a magnetic field, and γ is a
gyromagnetic ratio.
In addition to precession in the magnetic field, magnetization also experiences
relaxation. That is, once perturbed from equilibrium, the magnetization gradually tends to
approach the most-probable (Boltzmann distribution) population of spin-states. Therefore, Bloch
proposed a set of differential equations to represent precession and relaxation of magnetization in
magnetic field [44]. If the magnetic field is constant (B0) and in ̂ direction the equations are as
follow
(1.7)

(1.8)

(1.9)
where Mx and My are transverse component of magnetization, M0 is net equilibrium
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magnetization, Mz is the longitudinal component of net magnetization, M0 is the equilibrium
magnetization, T1 is a longitudinal relaxation time constant, and T2 is time constant for decay
of transverse magnetization components. The solutions of Eq. (1.9) is shown in Eq. (1.10)

[

]

(1.10)

and if we let Mxy = Mx + i My, Eq. (1.7) and (1.8) are rewritten as Eq. (1.11)

(

)

[(

)

]

[

]

(1.11)

the solution of transverse magnetization is shown in Eq. (1.12)

(1.12)
where ω0 = B0 γ, Larmor frequency
After a 90º RF pulse, the magnetization is flipped to the transverse plane, and decay of
the net magnetization, viewed in an on-resonance rotating frame (i.e., a reference frame rotating
about B0 with angular frequency ω0) can represented as Eq. (1.13)

(1.13)
Different tissues have their own specific field-strength-dependent T1 and T2 relaxation
time constants. MRI takes advantage of this property and utilizes different MR parameters to
bias measurements based upon T1 or T2 characteristics, so called T1- or T2- weighted images.
Fig. 1 – 11 demonstrates the different T1 and T2 relaxation times of brain tissue.
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Figure 1 – 11 White matter (WM), gray matter (GM), and cerebrospinal fluid (CSF) have
different T1 and T2 relaxation time. The specific MR parameters (i.e. TR or TE) can reveal
tissue contrast (A). Representative T1- and T2-weighted middle sagittal images of mouse brain
show different contrast. Image parameter: 30 mm × 30 mm × 1 mm; T1-weighted spin-echo
sequence with TR = 600 ms, TE = 25 ms, Average = 8; T2-weighted spin-echo sequence with
TR = 3,000 ms, TE = 100 ms, Average = 4.
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1.7.2 Diffusion NMR and MRI
The relationship of Brownian motion (self diffusion) of molecules and diffusivity in
microscopic view was described by Einstein in 1905 (Eq. (1.14)).
〈
where 〈

〉

(1.14)

〉 is the mean square displacement, D is the diffusion coefficient, and t is the

time interval. For the case of diffusion in 3-D, the mean square displacement is

.

Regarding macroscopic view, Fick’s 1st law describes that the movement of molecules
are from region of high concentration to low concentration by random molecular motion (Eq.
(1.15)).
(1.15)
where is diffusion flux, and
diffusion process implies

concentration gradient. Conservation of mass during the
. It leads to Fick’s 2nd law (Eq. (1.16))

(1.16)
Torrey proposed that this diffusional motion could be accounted for in the Bloch
equations by adding an additional term [47]. Subsequently, the new simultaneous equations (Eq.
(1.17) to Eq. (1.19)) become as below
(1.17)

(1.18)
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(1.19)
where D is diffusion coefficient
If the diffusion is isotropic, then, the Bloch-Torrey equations can be re-written as Eq.
(1.20), (1.21) and (1.22)
(1.20)

(1.21)

(1.22)
A decade later (1965), Stejskal and Tanner modified Hahn’s spin echo experiment and
designed the pulse gradient spin echo (PGSE) experiment with two identical magnetic gradients
before and after 180º RF pulse to encode the diffusing spin [48, 49] (Fig. 1 – 12). Let us again
define the complex transverse magnetization as Mxy = Mx + iMy. After adding diffusion terms
and considering gradients (Bz = B0+G·z, Bx = ½ (G·x) and = ½ (G·y)), Eq. (1.11) is rewritten as
Eq. (1.23)

(1.23)
where ω0 = B0 γ and Mxy, the complex transverse magnetization, which precesses about the z
axis with angular speed – ω0. Then, Eq. (1.24) is putting in Eq. (1.23) and obtaining Eq. (1.25)

m=

(1.24)
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(1.25)
the third term of Eq. (1.25) is the order of

, which is assumed to be negligible.

Therefore, Eq. (1.25) is rewritten as Eq. (1.26)
(1.26)
Now, if a constant magnetic field gradient G is applied and is collinear with B0. The
magnetization precesses in the resulting magnetic field
(1.27)
the gradient G is assumed uniform through whole sample and r is the position vector for a given
nucleus. The Eq. (1.26) is rewritten as Eq. (1.28)
(1.28)
In the absence of diffusion, φ in Eq. (1.28) can be written as Eq. (1.29), which represents
the transverse magnetization at any time point. φ(0) = A represents the transverse magnetization
immediately after the first 90º RF pulse
(1.29)
where
∫
After time τ, at which a 180° refocusing pulse is applied, Eq. (1.29) can be rewritten as Eq. (1.30)
[

]

(1.30)

where f ≡ F (τ), and it corresponds to the phase angle that has accumulated between 90º and 180º
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RF pulse, due to the time-varying applied diffusion gradients. If we want to correctly describe
the magnetization before the 180º RF pulse, the new parameter, ξ = 1 for t < τ and ξ = -1 for t > τ,
is introduced. Then, the Eq. (1.30) is modified as Eq. (1.31)
[

]

(1.31)

therefore, after 180º RF pulse, the second exponent is -2f, while the first exponent continues to
increase from F (τ) to F (2τ). A spin echo is formed when F (2τ) = 2f. Then, the second
exponential term is equal to one. Stejskal-Tanner assumed that the solution of equation 1.28 with
diffusion effects would take the same shape as in the non-diffusing case. They also let A be a
function of time, A(t), in the presence of diffusion.
Now, the Eq. (1.28) without diffusion is rewritten as Eq. (1.32)
[

]

[

[

]

]

(1.32)

where

(1.33)
and

(1.34)

The Laplacian term of Eq. (1.28) would be like Eq. (1.35)
[

[

]

]

[

]
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(1.35)

Substituting Eq. (1.35) into the Laplacian term of Eq. (1.28) and equating Eq. (1.32)
gives
[

]

(1.36)

Integrating Eq. (1.36) from t = 0 to t = 2τ gives Eq. (1.37)
[

]

[∫

]

∫

(1.37)

where

{
The definition of G (t) in this discrete time interval shows the simplest pulse gradient spin-echo
(PSGE) (Fig. 1 – 7). The final result of Eq. (1.37) is shown in Eq. (1.38)
[

]

(

)

(1.38)

where
(

)

(1.39)

Eq. (1.38) is the famous Stejskal-Tanner equation, and b value (Eq. (1.39)), the so-called
gradient-sensitization parameter, reflects how diffusion is weighted by G (the gradient strength),
δ (the duration of each gradient pulse), and Δ (the time between the two gradient pulses). D is a
diffusion coefficient, γ is gyromagnetic ratio, and the effective diffusion time (T) is Δ – δ/3.
Subsequently, according to Stejskal and Tanners’ report, applied pulse gradient reduced signal
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intensities (Fig. 1 – 13). According to Eq. (1.38), diffusion coefficient, D, is calculated from two
different intensities, A (2τ) and A (0), and two different b values.
Tissues are highly heterogeneous media that consists of various compartments and
barriers. Thus, water molecules are restricted by microstructures and interact with cell
membranes, and intracellular organelles [50]. The diffusion coefficient of water molecules is not
free. Therefore, Le Bihan introduced the apparent diffusion coefficient (ADC) [51] to replace
physical diffusion coefficient D. Diffusion MRI provides an approach to observe the water
displacement in tissues and reveals information about the presence of microscopic
obstacles/structures and geometric organization of tissues by ADC (Fig. 1 – 14).
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Figure 1 – 12 Stejskal-Tanner Pulse-Gradient Spin-Echo with square-wave diffusion sensitizing
gradients. G is gradient strength, δ is duration of diffusion sensitizing gradient, Δ is time interval
between diffusion-sensitizing gradient pair, and τ is the time interval between 90º and 180º RF
pulses.
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Figure 1 – 13 According to Stejskal-Tanner equation (Eq. (1.38)), applied pulse gradient
reduced signal intensity (there was phase difference among spins, and net magnetization was
decreased).Figure shows signal attenuation curves (mono-exponential decay) with different b
values (only changing gradient strengths) either parallel or perpendicular to mouse optic nerve
(highly coherent white-matter tract). The overall signal with gradient direction perpendicular to
optic nerve was higher than the other direction since spins were ‘trapped’ within and by
cylindrical axonal fibers, and thus could not easily move. When the diffusion gradient was
applied along the optic nerve, spins were not restricted by optic nerve. Subsequently, they were
affected by applied gradients easily and resulted in reduced signal due to obvious phase
difference. Signal decay for b values less than 1.4 and 0.7 ms/μm2 for perpendicular and parallel
direction was close to mono-exponential decay; the exponential decay constant within those
regions was the apparent diffusion coefficient (ADC).
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Figure 1 – 14 Diffusion-weighted image (DWI) of whole mouse brain (sagittal view) (A).
Diffusion-sensitizing gradients were applied perpendicular to page, producing images which
clearly reveal the optic nerve (A, red arrow). Based on the result in (A), we adjusted another
image plan that was perpendicular to the optic nerves. Then, we could obtain another two DWIs
with gradient direction from left to right with two b values (B). The DWIs in (A) and (B, which
was applied with higher b value) show that the surrounding CSF was suppressed and reflected
optic nerve structure clearly. According to Stejskal-Tanner equation (Eq. (1.38)), we calculated
ADC map (C) from two DWIs (B). The ADC of optic nerves were lower than other moues
brain tissues suggests that applied gradient was perpendicular to optic nerves, and spins in the
optic nerves didn’t have severe phase differences. Comparing to other mouse brain tissue, the
signal intensity of optic nerves is considerably higher.
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1.8 Magnetic Resonance Imaging (MRI) as a bio-marker to assess functional deficits
The discussion in the section 1.7.1 shows that MRI could reflect tissue contrast due to
different T1 and T2 relaxation time. The first 2D MR image was introduced by Lauterbur [52].
In that paper, he used paramagnetic Mn2+ to show relaxation time could affect signal intensity.
Therefore, Mn2+ was the first MRI contrast agent. Recently, manganese-enhanced MRI (MEMRI)
has been widely used in animal studies, including mouse [53, 54, 11], rat [55-57], songbird [58],
and monkey[59]. Manganese (Mn2+), a calcium (Ca2+) analog, enters cells through voltage-gated
Ca2+ channels. After entry into the cell, Mn2+ is transported by fast axonal transport in vesicles
and released into the synaptic cleft [54, 60]. Because Mn2+ is paramagnetic, it reduces T1
relaxation in tissue water and produces concentration-dependent hyper-intensities in T1weighted (T1W) imaging [61] (Fig. 1 – 15). Therefore, Mn2+ can serve as both contrast agent
and axonal transport tracer. Taking the visual system as an example, MEMRI provides a
potential approach to track the pathway from retinal ganglion cell (inner layer of retina), optic
nerve, to contralateral optic tract and superior colliculus. However, the cellular toxicity of Mn2+
has long been recognized [61, 62]. In Chapter 2, we compared functional effects of topical
loading or intravitreal injection with working dosage. Briefly, topical loading with higher
concentration of MnCl2 damaged photoreceptor layers but not optic nerve. After optimizing
working dosage, we applied MEMRI to EAE mice with optic neuritis to compare differences in
axonal transport rates. We found that at the onset of optic neuritis in EAE mice, a significantly
decreased axonal transport rate was observable (detailed in Chapter 3).
In section 1.7.2, we mentioned that ADC from diffusion MRI measurement can reflect
the tissue structures or geometric orientation. We further proposed that ADC is a potential means
to directly reveal axonal activity. Le Bihan et al. have reported that in human visual cortex,
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signal intensity increased (ADC decreased) in diffusion-weighted image (DWI) during visual
stimulation [63]. However, Miller et al. reported that such signal/ADC change in human visual
cortex might result from a vascular contribution [64]. In white matter, blood oxygen level
dependent (BOLD) fMRI is not easy to perform due to less blood flow and blood volume [65].
Therefore, in Chapter 4, we introduced our recent finding that during visual stimulation,
decreased ADC in mouse optic nerve (gradient direction was perpendicular to optic nerve) was
observed and excluded vascular contribution as well. Such ADC change might be related to
extracellular space shrinkage due to stimulation-associated change in size or shape of glial cells
or osmotic water shift across membrane. In Chapter 5, we further applied diffusion fMRI to EAE
mice with optic neuritis. Then, we compared ADC change of EAE and sham mice during visual
stimulation. The results showed that activation-associated ADC change of EAE mice was less
than sham mice.
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Figure 1 – 15 The T1 relaxation curves of mouse optic nerve with and without Mn2+ loading at a
4.7 T animal scanner with multiple TR (from 200 ms to 10 s, figure only showed TR from 0 to
6.5 s) and minimal TE using stand spin-echo sequence (A). The measurement was performed one
day after intravitreal Mn2+ injection with 0.25μL of 0.2 M MnCl2 (A). Open symbols are
experimental data and solid lines are fitting curves, and T1 of Mn2+-loading and normal mouse
optic nerve is ~1.1 and 1.5 s, respectively. Since Mn2+ reduces T1 relaxation time in tissue water,
Mn2+-loading mouse optic nerve shows hyper-intensities in T1-weighted image (B, left optic
nerve).

33

1.9 Reference
1.

Filippi, M., et al., Association between pathological and MRI findings in multiple
sclerosis. Lancet Neurol, 2012. 11(4): p. 349-60.

2.

Waxman, S.G., Axonal conduction and injury in multiple sclerosis: the role of sodium
channels. Nat Rev Neurosci, 2006. 7(12): p. 932-41.

3.

Mao, P. and P.H. Reddy, Is multiple sclerosis a mitochondrial disease? Biochim Biophys
Acta, 2010. 1802(1): p. 66-79.

4.

Compston, A. and A. Coles, Multiple sclerosis. Lancet, 2008. 372(9648): p. 1502-17.

5.

Simmons, S.B., et al., Modeling the heterogeneity of multiple sclerosis in animals. Trends
Immunol, 2013.

6.

Lublin, F.D. and S.C. Reingold, Defining the clinical course of multiple sclerosis: results
of an international survey. National Multiple Sclerosis Society (USA) Advisory
Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology, 1996.
46(4): p. 907-11.

7.

Ohno, N., et al., Myelination and axonal electrical activity modulate the distribution and
motility of mitochondria at CNS nodes of Ranvier. J Neurosci, 2011. 31(20): p. 7249-58.

8.

Kann, O. and R. Kovacs, Mitochondria and neuronal activity. Am J Physiol Cell Physiol,
2007. 292(2): p. C641-57.

9.

Stys, P.K., General mechanisms of axonal damage and its prevention. J Neurol Sci, 2005.
233(1-2): p. 3-13.

10.

Su, K.G., et al., Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
Curr Neurol Neurosci Rep, 2009. 9(5): p. 411-7.

11.

Sharma, R., et al., Hyperglycemia induces oxidative stress and impairs axonal transport
rates in mice. PLoS One, 2010. 5(10): p. e13463.

12.

Smith, K.J. and H. Lassmann, The role of nitric oxide in multiple sclerosis. Lancet Neurol,
2002. 1(4): p. 232-41.

13.

Hooper, D.C., et al., Prevention of experimental allergic encephalomyelitis by targeting
nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc
Natl Acad Sci U S A, 1997. 94(6): p. 2528-33.

14.

Kornek, B., et al., Distribution of a calcium channel subunit in dystrophic axons in
multiple sclerosis and experimental autoimmune encephalomyelitis. Brain, 2001. 124(Pt
6): p. 1114-24.

34

15.

Andrews, H.E., et al., Mitochondrial dysfunction plays a key role in progressive axonal
loss in Multiple Sclerosis. Med Hypotheses, 2005. 64(4): p. 669-77.

16.

Beck, R.W., et al., High- and low-risk profiles for the development of multiple sclerosis
within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch
Ophthalmol, 2003. 121(7): p. 944-9.

17.

Beck, R.W., et al., The effect of corticosteroids for acute optic neuritis on the subsequent
development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med, 1993.
329(24): p. 1764-9.

18.

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
Arch Neurol, 2008. 65(6): p. 727-32.

19.

Arnold, A.C., Evolving management of optic neuritis and multiple sclerosis. Am J
Ophthalmol, 2005. 139(6): p. 1101-8.

20.

Polman, C.H., et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the
McDonald criteria. Ann Neurol, 2011. 69(2): p. 292-302.

21.

Brusa, A., S.J. Jones, and G.T. Plant, Long-term remyelination after optic neuritis: A 2year visual evoked potential and psychophysical serial study. Brain, 2001. 124(Pt 3): p.
468-79.

22.

Kupersmith, M.J., et al., Contrast-enhanced MRI in acute optic neuritis: relationship to
visual performance. Brain, 2002. 125(Pt 4): p. 812-22.

23.

Naismith, R.T., et al., Optical coherence tomography is less sensitive than visual evoked
potentials in optic neuritis. Neurology, 2009. 73(1): p. 46-52.

24.

Frohman, E.M., L.J. Balcer, and P.A. Calabresi, Multiple sclerosis: can retinal imaging
accurately detect optic neuritis? Nat Rev Neurol, 2010. 6(3): p. 125-6.

25.

Berard, J.L., et al., Characterization of relapsing-remitting and chronic forms of
experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia, 2010. 58(4): p. 43445.

26.

Gold, R., C. Linington, and H. Lassmann, Understanding pathogenesis and therapy of
multiple sclerosis via animal models: 70 years of merits and culprits in experimental
autoimmune encephalomyelitis research. Brain, 2006. 129(Pt 8): p. 1953-71.

27.

Matsunaga, Y., et al., Visual functional and histopathological correlation in experimental
autoimmune optic neuritis. Invest Ophthalmol Vis Sci, 2012. 53(11): p. 6964-71.

28.

Meyer, R., et al., Acute neuronal apoptosis in a rat model of multiple sclerosis. J
Neurosci, 2001. 21(16): p. 6214-20.

35

29.

Bettelli, E., et al., Myelin oligodendrocyte glycoprotein-specific T cell receptor
transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med, 2003.
197(9): p. 1073-81.

30.

Ridder, W.H., 3rd and S. Nusinowitz, The visual evoked potential in the mouse--origins
and response characteristics. Vision Res, 2006. 46(6-7): p. 902-13.

31.

Andermann, M.L., et al., Functional specialization of mouse higher visual cortical areas.
Neuron, 2011. 72(6): p. 1025-39.

32.

Godement, P., J. Salaün, and C.A. Mason, Retinal axon pathfinding in the optic chiasm:
Divergence of crossed and uncrossed fibers. Neuron, 1990. 5(2): p. 173-186.

33.

Douglas, R.M., et al., Independent visual threshold measurements in the two eyes of
freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci,
2005. 22(5): p. 677-84.

34.

Prusky, G.T., et al., Rapid quantification of adult and developing mouse spatial vision
using a virtual optomotor system. Invest Ophthalmol Vis Sci, 2004. 45(12): p. 4611-6.

35.

Chiang, C.W., et al., Acute visual function impairment in EAE is primarily caused by
optic nerve inflammation as assessed by DBSI. Proc. Intl. Soc. Mag. Reson. Med. 20,
3085, 2012.

36.

Ge, Y., Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol, 2006. 27(6):
p. 1165-76.

37.

Boretius, S., et al., MRI of optic neuritis in a rat model. Neuroimage, 2008. 41(2): p. 32334.

38.

Diem, R., et al., Autoimmune optic neuritis in the common marmoset monkey:
comparison of visual evoked potentials with MRI and histopathology. Invest Ophthalmol
Vis Sci, 2008. 49(8): p. 3707-14.

39.

Gadjanski, I., et al., Role of n-type voltage-dependent calcium channels in autoimmune
optic neuritis. Ann Neurol, 2009. 66(1): p. 81-93.

40.

Guy, J., MRI in experimental inflammatory and mitochondrial optic neuropathies. NMR
Biomed, 2008. 21(9): p. 968-77.

41.

Hickman, S.J., Optic nerve imaging in multiple sclerosis. J Neuroimaging, 2007. 17
Suppl 1: p. 42S-45S.

42.

Sun, S.W., et al., Selective vulnerability of cerebral white matter in a murine model of
multiple sclerosis detected using diffusion tensor imaging. Neurobiol Dis, 2007. 28(1): p.
30-8.

36

43.

Purcell, E.M., H.C. Torrey, and R.V. Pound, Resonance Absorption by Nuclear Magnetic
Moments in a Solid. Physical Review, 1946. 69(1-2): p. 37-38.

44.

Bloch, F., Nuclear Induction. Physical Review, 1946. 70(7-8): p. 460-474.

45.

Buxton, R.B., Introduction to functional magnetic resonance imaging : principles and
techniques. 2nd ed2009, Cambridge ; New York: Cambridge University Press. p. 425439.

46.

Plewes, D.B. and W. Kucharczyk, Physics of MRI: A primer. Journal of Magnetic
Resonance Imaging, 2012. 35(5): p. 1038-1054.

47.

Torrey, H.C., Bloch Equations with Diffusion Terms. Physical Review, 1956. 104(3): p.
563-565.

48.

Stejskal, E.O. and J.E. Tanner, Spin Diffusion Measurements: Spin Echoes in the
Presence of a Time-Dependent Field Gradient. The Journal of Chemical Physics, 1965.
42(1): p. 288-292.

49.

Kuchel, P.W., et al., Stejskal-tanner equation derived in full. Concepts in Magnetic
Resonance Part A, 2012. 40A(5): p. 205-214.

50.

Hagmann, P., et al., Understanding diffusion MR imaging techniques: from scalar
diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics, 2006.
26 Suppl 1: p. S205-23.

51.

Le Bihan, D., et al., MR imaging of intravoxel incoherent motions: application to
diffusion and perfusion in neurologic disorders. Radiology, 1986. 161(2): p. 401-7.

52.

Lauterbur, P.C., Image Formation by Induced Local Interactions - Examples Employing
Nuclear Magnetic-Resonance. Nature, 1973. 242(5394): p. 190-191.

53.

Bearer, E.L., et al., Role of neuronal activity and kinesin on tract tracing by manganeseenhanced MRI (MEMRI). Neuroimage, 2007. 37 Suppl 1: p. S37-46.

54.

Smith, K.D., et al., In vivo axonal transport rates decrease in a mouse model of
Alzheimer's disease. Neuroimage, 2007. 35(4): p. 1401-8.

55.

Chan, K.C., et al., Evaluation of the retina and optic nerve in a rat model of chronic
glaucoma using in vivo manganese-enhanced magnetic resonance imaging. Neuroimage,
2008. 40(3): p. 1166-74.

56.

Olsen, O., et al., Manganese transport in the rat optic nerve evaluated with spatial- and
time-resolved magnetic resonance imaging. J Magn Reson Imaging, 2010. 32(3): p. 55160.

37

57.

Watanabe, T., J. Frahm, and T. Michaelis, Functional mapping of neural pathways in
rodent brain in vivo using manganese-enhanced three-dimensional magnetic resonance
imaging. NMR in Biomedicine, 2004. 17(8): p. 554-568.

58.

Van der Linden, A., et al., In vivo manganese-enhanced magnetic resonance imaging
reveals connections and functional properties of the songbird vocal control system.
Neuroscience, 2002. 112(2): p. 467-474.

59.

Saleem, K.S., et al., Magnetic Resonance Imaging of Neuronal Connections in the
Macaque Monkey. Neuron, 2002. 34(5): p. 685-700.

60.

Millecamps, S. and J.P. Julien, Axonal transport deficits and neurodegenerative diseases.
Nat Rev Neurosci, 2013. 14(3): p. 161-76.

61.

Silva, A.C., et al., Manganese-enhanced magnetic resonance imaging (MEMRI):
methodological and practical considerations. NMR in Biomedicine, 2004. 17(8): p. 532543.

62.

Koretsky, A.P. and A.C. Silva, Manganese-enhanced magnetic resonance imaging
(MEMRI). NMR Biomed, 2004. 17(8): p. 527-31.

63.

Le Bihan, D., et al., Direct and fast detection of neuronal activation in the human brain
with diffusion MRI. Proc Natl Acad Sci U S A, 2006. 103(21): p. 8263-8.

64.

Miller, K.L., et al., Evidence for a vascular contribution to diffusion FMRI at high b
value. Proceedings of the National Academy of Sciences, 2007. 104(52): p. 20967-20972.

65.

Rostrup, E., et al., Regional differences in the CBF and BOLD responses to hypercapnia:
a combined PET and fMRI study. Neuroimage, 2000. 11(2): p. 87-97.

38

Chapter 2
Manganese-Enhanced MRI (MEMRI) via Topical Loading of Mn2+
Significantly Impairs Mouse Visual Acuity: A Comparison with Intravitreal
Injection
This chapter represents the latest version of a manuscript that is targeted for submission to NMR
in Biomedicine.
(Tsen-Hsuan Lin, Chia-Wen Chiang, Kathryn Trinkaus, William M. Spees, Peng Sun, and
Sheng-Kwei Song)

Abstract
Purpose Manganese enhanced MRI (MEMRI) with topical loading of MnCl2 provides
comparable optic nerve enhancement as seen by intravitreal injection. However, the impact of
this novel and noninvasive Mn2+ loading method on visual function remains undefined. The
objective of this study is to determine the optimal topical Mn2+ loading dosage for MEMRI and
to assess visual function after MnCl2 loading. Intravitreal administration was performed to
compare the two approaches of MnCl2 loading.
Methods Twenty-four hours after topical loading of 0, 0.5, 0.75, and 1M MnCl2, T1-weighted
(T1W), T2-weighted (T2W), diffusion tensor image (DTI) and visual acuity were performed to
determine the best topical loading dosage for MEMRI measurements and to assess the integrity

39

of retina and optic nerves. Mice were perfusion fixed immediately after in vivo experiments for
H&E and immunohistochemistry staining.
Results Topical loading of 1 M MnCl2 damaged the retinal photoreceptor layer with no
detectable damage to optic nerves. For the topical loading, 0.75-M MnCl2 was required to see
sufficient enhancement of optic nerve. At this concentration the visual function was significantly
affected followed by a slow recovery. Intravitreal injection (0.25 µL of 0.2 M MnCl2) slightly
affected visual acuity with full recovery a day later.
Conclusion Intravitreal Mn2+ injection provides more reproducible results with less adverse side
effects than topical loading.
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2.1 Introduction
Manganese (Mn2+), as a calcium (Ca2+) analog, enters cell bodies through voltage-gated
Ca2+ channels. After entry into the cell, Mn2+ is transported by fast axonal transport in vesicles
and released into the synaptic cleft [1]. Mn2+ produces a concentration-dependent shortening of
tissue T1 due to its paramagnetic property. Therefore, Mn2+ can serve as both contrast agent and
axonal transport tracer. T1-weighted (T1W) imaging is usually performed to monitor real-time
Mn2+ transport reflected by the extent of enhancement in T1W MRI [2]. Therefore, MEMRI
provides a potential approach to further explore the visual pathway from retinal ganglion cells,
optic nerve, to contralateral optic tract and superior colliculus [3]. Indeed, manganese-enhanced
MRI (MEMRI) has recently been used to investigate optic nerve axonal integrity [4-7], retinal
projections to the superior colliculus through intravitreal injection of MnCl2 [8], or layer-specific
calcium-dependent retinal fMRI activation [9, 10].
The cellular toxicity of Mn2+ has long been recognized as overexposure causes
Parkinsonism [11]. Therefore, it is important to determine optimal Mn2+ dosing, which is a
tradeoff between maximizing MR detectability and minimizing toxicity [12]. The toxicity of
MnCl2 after intravitreal injection has been examined previously by histology and visual function
measurements [13-15, 7, 16]. In an attempt to remedy the invasive intraocular injection of MnCl2,
Sun et al. proposed to deliver Mn2+ through topical loading [17]. Topical loading is a simple,
noninvasive approach for Mn2+ delivery, achieved by dropping MnCl2 solution directly onto the
eye. The effect of repetitive topical MnCl2 loading was recently examined reporting RGC loss
after three bi-weekly applications of 1 M MnCl2 while no RGC loss was observed after three
monthly applications [18]. Corneal thickening was also observed after seven bi-weekly
applications [18]. It appeared that increasing the time interval between repetitive topical
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applications reduced adverse effects seen in RGC and cornea. In this study, the effect of topical
and intravitreal loading of MnCl2 was examined by assessing post-loading visual acuity and
structural integrity of both retina (by high resolution in vivo T2-weighted MRI and histology)
and optic nerves ( by in vivo diffusion tensor imaging, i.e., DTI). Results suggest that intravitreal
injection of MnCl2 is safe with limited adverse effects when administered in small volume and
low doses, sufficient to monitor axonal transport.

2.2 Materials and Methods
All experimental procedures were approved by Washington University’s Animal Studies
Committee and conformed to the NIH Policy on Responsibility for Care and Use of Animals and
the ARVO Statement for the Use Animals in Ophthalmic and Vision Research.
2.2.1 Topical MnCl2 Loading
Thirty-five female C57BL/6 mice obtained from Jackson Laboratory (Bar Harbor, ME) at
8 weeks of age underwent topical loading of 0 (n=5), 0.5 (n=5), 0.75 (n=15), or 1 M (n=10) of
MnCl2 in 0.9% saline. After anesthetized using 1.5-2% isoflurane/oxygen, a 30-µL drop of
MnCl2 was introduced covering the entire right eye. An additional 10µL of MnCl2 was applied
every 15 min to maintain the topical-fluid volume, different from the original procedure by Sun
et al.[17], assuring a consistent loading among various lab personnel.
2.2.2 Intravitreal MnCl2 Injection
An additional twenty 8-week old female C57BL/6 mice were employed to compare the
“safe” injection volumes of 0.25 and 2 µL using saline (n=5 each group), and the “safe” dose
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using 0.25 (n=5) and 0.125 (n=5) µL of 0.2-M MnCl2 in saline. Mice, under 1.5-2%
isoflurane/oxygen anesthesia, were placed on a custom-made head holder for intravitreal
injection at 3-µL/min using a 34-gauge needle connected to a micro-injection pump (WPI
Instrument, FL). After infusion, the needle was left in place for an extra 1 minute before
withdrawal. A drop of topical antibiotic was applied after removing the injection needle [19].
2.2.3 Visual Acuity Assessment
Visual acuity (VA) was assessed using the OptoMotry Virtual Optometry System,
(CerebralMechanics, Inc., Canada). Mice were placed on the platform inside the chamber with
virtual rotating columns projected on four LCD monitors surrounding it. The spatial frequency in
cycle/degree (c/d) starting from 0.1 c/d was incremented in steps of 0.05 c/d until the mouse
stopped responding to the projected visual patterns, which was recorded as the VA [20, 21].
Thirty normal C57BL/6 mice were measured to establish the baseline VA for naïve animals. VA
was measured before MnCl2 loading and at days 1 through 7 after topical MnCl2 loading, and at
4, 24, and 48 hours after intravitreal injection.
2.2.4 MRI: DTI and T1-weighted imaging of the visual pathway
Twenty-four hours after topical or intravitreal MnCl2 loading, MRI measurements were
performed on a 4.7T Agilent DiectDrive small-animal MRI system (Agilent Technologies, CA)
equipped with a Magnex/Agilent HD gradient coil set (Magnex, Oxford, UK) with pulse gradient
strength up to 58 G/cm and a gradient rise time ≤ 295 µs. Mice were anesthetized by
isoflurane/oxygen (1.5%). Respiratory rate and body temperature were monitored during
experiments using a MR compatible animal monitoring system (SA Instrument, Inc., NY). The
body temperature was maintained at 37C with a regulated circulating warm water pad placed
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underneath mouse body along with regulated warm air blown into the magnet bore. An activelydecoupled 1.7-cm receive coil was placed on top of the mouse head. The animal holder assembly,
including the receive coil was placed in an 8-cm active-decoupled volume transmit coil [22, 23].
2.2.4.1 T1-weighted Imaging
A 3D gradient echo sequence was employed to image mouse brain with the following
parameters: TR= 15 ms, TE= 2.63 ms, flip angle 20º, number of averages 16, FOV 15×15×22
mm3, data matrix size 128×128×64 (zero-filled to 256×256×128). Regions of interest (ROI) were
manually outlined according to a previously published protocol[17] on the extracted 2D images
containing retina, optic nerve, and superior colliculus using ImageJ software (NIH,
http://bigwww.epfl.ch/sage/soft/watershed/, US). The ROI of the Mn2+-loaded structures along
the visual pathway was outlined and mean signal intensity was obtained using ImageJ. The
signal intensity of the loaded ROI was normalized by the contralateral mean intensity to correct
scan-to-scan sensitivity differences resulting from variable sample loading.

2.2.4.2 DTI of Optic Nerve
Optic nerve DTI was performed using a multi-echo spin-echo diffusion weighted imaging
sequence (Tu et al., 2010) with the following parameters: TR=1.5 s, TE=34 ms (first echo time,
including required time for diffusion-weighting gradients), inter-echo delay time 19 ms, FOV
22.5×22.5 mm2, matrix size 192×192 (zero-filled to 384×384); in-plane resolution 117×117 mm2
(prior to zero-filling), slice thickness 0.5 mm, two diffusion-sensitizing factors (b value) 0.0 and
1.0 ms/µm2 (with δ = 5 ms and Δ = 18 ms). The standard six-direction diffusion encoding
scheme was used, with [Gx, Gy, Gz] = [1, 1, 0], [1, 0, 1], [0, 1, 1], [-1, 1, 0], [0, -1, 1], and [1, 0, 44

1]. The image plane was adjusted to be as nearly perpendicular to optic nerve as possible to
minimize partial volume effects. Fractional anisotropy (FA), axial (||) and radial () diffusivity
maps were generated from the image data by programs written in Matlab (MathWorks, Natick,
MA).
2.2.5 T2-weighted Imaging of Retina
For retinal imaging, mice were anesthetized by intraperitoneal injection of ketamine (87
mg/kg) and xylazine (13 mg/kg) followed by constant subcutaneous infusion of ketamine (54
mg/kg/h)/xylazine (4 mg/kg/h). The infusion rate was adjusted to maintain the respiratory rate
between 150 - 210 breaths/min during imaging. Retina imaging was performed on an Agilent
11.74 T DirectDrive small-animal MRI system using a spin-echo sequence with the following
parameters: TR = 2 s, TE = 34 ms, FOV 12×12 mm2, matrix size 256×256 (zero-filled to
512×512); in-plane resolution 47×47 µm2 (prior to zero-filling), slice thickness 0.4 mm. All
images were acquired on a nasal-temporal slice bisecting the eye through the retina and optic
nerve head.
2.2.6 Histology
2.2.6.1 Optic nerve
Following MR experiments, mice were perfused with 4 % paraformaldehyde in
phosphate-buffered saline (PBS). Brains were excised and post-fixed in fixative for 24 hours
then transferred to 1% PBS for storage at 4ºC until histological analysis. Mouse optic nerves
were embedded in 2 % agar gel followed by paraffin embedding [24]. Five-µm thick transverse
slices were sectioned for immunohistochemical staining. All sectioned tissues were
deparaffinized, rehydrated, and blocked in solution mixed with 1% bovine serum albumin (BSA)
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and 2% Triton-X100 for an hour at room temperature to prevent non-specific binding and to
increase antibody permeability. Slides were incubated in monoclonal anti-phosphorylated
neurofilament antibody (SMI-31; 1:2000, Covance) to stain non-injured axons, or in rabbit antimyelin basic protein (MBP) antibody (1:1000 Sigma-Aldrich, MO) to stain myelin sheath at 4ºC
overnight. After rinsing, goat anti-mouse IgG or goat anti-rabbit IgG conjugated Alexa 488
(1:800, Invitrogen, CA) were applied to visualize immunoreactivity of phosphorylated
neurofilaments and MBP. Finally, slides were covered using Vectashield Mounting Medium
with 4´,6-diamidino-2-phenylindole (DAPI) (Vector Laboratory, Inc., Burlingame, CA).
Histological slides were examined with Nikon Eclipse 80i fluorescence microscope. Images were
captured with a black-and-white CCD camera using MetaMorph software (Universal Imaging
Corporation, Sunnyvale, CA).
2.2.6.2 Retina
Mouse eyes were flash-frozen immediately after enucleation to avoid dehydration and
fixation induced tissue distortion. Frozen-cut 8-µm-thick tissue sections were stained with
hematoxylin and eosin (H&E) to assess the integrity of multiple retinal layers. Histological slices
were scanned with Olympus NanoZoomer slide scanner (Hamamatsu Photonics, Hamamatsu,
Japan). For quantitative analysis of H&E staining, scanned images were exported with NDP
viewer software (Hamamatsu Photonics, Hamamatsu, Japan) with 20× objective. ROIs were
selected to contain the retina segment with proximal and distal ends located at 250 and 800 µm
away from the optic nerve head on both sides of the nerve head [25]. Within the ROIs, the retinal
thickness was measured from nerve fiber layer to retina pigment epithelium every 55 µm (i.e., 10
measurements total). Ten measurements were averaged as the representative thickness for that
side of retina.
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2.2.6.3 Statistical analysis
Multiple comparisons for T1W enhancement in retina, optic nerve, and superior
colliculus after Mn2+ loading were performed using a linear repeated measures model with
adjustment for multiple testing using Tukey's HSD (honest significant difference). A linear
repeated measures model was used to estimate the mean difference in VA between loaded and
contralateral control eyes by dosages and day of experiment (from baseline to day 7 ). The effect
of Mn2+ loading on the mean retinal thickness was assessed using a linear model on a log scale in
each of the five study groups. Each Mn2+ treated group was compared with the saline control. Pvalues for the difference in mean retinal thickness were adjusted for multiple tests using Tukey’s
HSD.

2.3 Results
2.3.1 Topical MnCl2 Loading
2.3.1.1 Manganese Enhanced T1W MRI
T1-weighted images of 1-M MnCl2 loaded visual pathway including ipsilateral retina
and optic nerve (ON), and contralateral lateral geniculate nucleus (LGN) and superior colliculus
(SC) clearly demonstrated signal enhancement on these structures (Fig. 2 – 1A). The image of
retina and optic nerve with 0.5, 0.75, and 1 M of MnCl2 loading (Fig. 2 – 1B) suggested that both
1 and 0.75 M of MnCl2 loading led to discernible signal enhancement in optic nerve while 0.5 M
did not. Compared to the saline group, the group-averaged ROI analysis (Fig. 2 – 1C)
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demonstrated that 0.75 and 1 M of MnCl2 loading significantly enhanced all structures along the
visual pathway.
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Figure 2 – 1 Representative T1W images acquired from a mouse brain at 24 hours after topical
MnCl2 loading (A), ipsilateral retina and optic nerve (ON), and contralateral lateral geniculate
nucleus (LGN) and superior colliculus (SC) are enhanced with topical loading (arrows). The
oblique images (B) bisecting retina and optic nerve after topical loading of 1, 0.75, and 0.5M
MnCl2 suggest that 0.75M MnCl2 was sufficient to produce discernible enhancement of optic
nerve. Bar graphs (C) demonstrate the signal intensity ratio between labeled and control retina,
ON, and SC. With 1 and 0.75M MnCl2 loading, a significant enhancement of the structures along
the visual system (retina, ON, LGN, SC) was clearly seen. In contrast, only slight retinal
enhancement was seen with 0.5M MnCl2 loading. Therefore, 0.75M was the concentration
selected for topical loading in this study.
* indicates that P < 0.005 compared to saline group via Tukey HSD test.
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2.3.1.2 Visual Acuity
The VA of normal female C57BL/6 mice is 0.37 ± 0.03 c/d (mean ± SD; n=30). Topical
loading of 1-M MnCl2 caused total blindness (VA ~ 0 c/d) at one day after loading without
recovery up to 7 days after loading (open squares; Fig. 2 – 2). A significant VA decrease in eyes
following 0.75-M MnCl2 loading was also observed (open circles; Fig. 2 – 2). However, the
decreased VA gradually recovered to the normal range at day 5 (VA ≥ 0.3 c/d). Contralateral
control eyes in animals treated without 1 and 0.75-M MnCl2 loading were not affected
throughout the time course (filled symbols, Fig. 2 – 2). Mice topically loaded with 0.5M MnCl2
exhibited a slight VA decrease at one day after loading and recovered to normal at day 2; salineloaded eyes exhibited normal VA throughout the time course (data not shown).
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Figure 2 – 2 Visual acuity was measured daily in eyes after topical loading with 0.75 and 1M
MnCl2 (open symbols), and in contralateral, control eyes (filled symbols). Tests for difference
between the dose groups indicate that there is no difference at baseline or on the first day of
treatment. Between days 2 and 7, however, the difference between loaded and control eyes is not
the same in the two different dosage groups (p-values < 0.0001 at days 2-7). At one day after 1M
of MnCl2 loading, the visual acuity decreased to zero (completely blind) and did not recover
throughout the 7-day time course. In contrast, one day after 0.75M of MnCl2 loading visual
acuity decreased to 0.1c/d and recovered beginning on Day 2 (p < 0.05, compared to 1M loading
eyes) until recovering back to the normal range by Day 6.
Note 1: mean VA of normal B6 mice (n=30) is 0.36 ± 0.03 (c/d; mean ± SD)
Note 2: c/d denotes units of cycles per degree
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2.3.1.3 DTI and Immunohistochemistry of Optic Nerve
In vivo DTI of optic nerves was performed at days 1 and 7 after 1M MnCl2 loading (VA
= 0 c/d). Color-coded FA, maps derived from DTI analysis clearly delineated the optic nerves
(Fig. 2 – 3A). There was no statistically-significant difference in group-averaged || and 
between the loaded and control optic nerves at days 1 and 7 after MnCl2 loading (Fig. 2 – 3B).
These DTI findings suggested that there was no detectable axon or myelin injury after topical
MnCl2 loading [26], supported by the immunohistochemical staining of phosphorylated
neurofilaments (SMI-31; green dots in Fig. 2 – 3C) and myelin basic protein (MBP; red rings in
Fig. 2 – 3C) from the same nerves after in vivo DTI.
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Figure 2 – 3 Brain DTI maps, containing optic nerves, from mice at one and seven days after
topical loading of 1M MnCl2 were examined to assess the effect of Mn2+ on axonal integrity. The
region-of-interest (ROI) based analysis was performed on diffusion metrics, including fractional
anisotropy (FA), axial (||), and radial () diffusivity, from each optic nerve (A, outline in red).
At one and seven days after 1M of MnCl2 loading, there was no difference in || and  between
the optic nerves from the control (B, black bars) and loaded (white bars) eyes suggesting no axon
or myelin injury upon Mn2+ loading. The matched immunohistochemical staining of
phosphorylated neurofilament (SMI-31) and myelin basic protein (MBP) strongly support the
axonal and myelin sheath integrity seen by in-vivo DTI (C).
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2.3.1.4 T2W Images and H&E Staining of Retina
T2W images acquired from retinas in control and topical-loading mice at day 7 after 1M
MnCl2 loading revealed the previously reported dark-bright-dark layer contrast of the control
retinas [27, 28] (Fig. 2 – 4A and 2 – 4B). Significant thinning of the retina was seen in the 1M
MnCl2 loaded eyes (Fig. 2 – 4C and 2 – 4D). Retinal layers examined by H&E staining showed
significant cell swelling (~26 % increased thickness) at day 1 (VA = 0 c/d; the time point of best
T1W enhancement) and significant retinal thinning (~31 %) at day 7 (VA = 0 c/d) after 1M
MnCl2 loading (Fig. 2 – 4E and 2 – 4F). A slight swelling of the retina was seen at day 1 after
0.75M MnCl2 loading with recovery to the normal thickness at day 5 (VA ≥ 0.3 c/d). Retina with
saline loading exhibited the same thickness as that reported in the literature for normal mice (Fig.
2 – 4E and 2 – 4F) [25, 19].
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Figure 2 – 4 In-vivo T2-weighted (T2W) imaging was performed to compare the retinal
thickness between the saline (sham) (A) and MnCl2-loaded (B) eyes. Zoom-in images of mouse
retina (C and D) seven days after topical loading of 1M of MnCl2 exhibit typical T2W MRI
features of a mouse retina wherein sclera appears dark (white stars), choroid is bright (black
arrows), and retinal layers (white double-headed arrows) exhibit intensities between sclera and
choroid. Clear thinning in Mn2+ loaded retina was seen 7 days after topical loading in T2W MRI.
The hematoxylin and eosin (H&E) staining of the frozen-embedded retina confirmed the MRI
detected retinal thinning (E). At 24 hours after 1 M MnCl2 loading, heterogeneous retinal
swelling was observed. On day 7 after 1M MnCl2 loading, photoreceptor layers degeneration
was visible. 0.75 M MnCl2 loading caused retina slightly swelling at day 1 but recovery at day 5
(E). To quantify the extent of retinal thickness change, H&E images were analyzed (F). A linear
model was used to estimate mean retinal thickness on a log scale in each of the 5 study groups.
Each of the MnCl2 treated groups was compared with the saline control. P-values for the
difference in mean retinal thickness are adjusted for multiple testing using Tukey's HSD test.
One day after 1M MnCl2 loading, transient significant swelling of retina (p < 0.005, with
blindness) was seen followed by significant retinal thinning at Day 7 (p < 0.005, with no
recovery of visual function). At 0.75M of MnCl2 loading, mild retinal swelling was seen at 1 day
(significantly-decreased VA without blindness), which returned to normal thickness 7 days after
loading (visual acuity returned to normal by 5-6 days post-loading).
Diamond symbols: mean value
Scale bar: 100 µm
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2.3.2 Effect of Intravitreal Injection
2.3.2.1 Volume Effect
There was no change in VA of eyes receiving intravitreal 0.25-µL saline injection (Fig. 2
– 5A). In contrast, VA impairment was seen in eyes at 4 and 24 hours after intravitreal 2-µL
saline injection, which recovered at 48 hours (Fig. 2 – 5A). Histological examinations revealed
significant retinal swelling (~17% increase in thickness) at 24 hours after 2µL-saline injection
while no detectable difference was seen in eyes with 0.25-µL saline injection or topical saline
loading (Fig. 2 – 5C and 2 – 5D).
2.3.2.2 Dose Effect
Sufficient T1W enhancement in the visual pathway was seen 24 hours after intravitreal
injection of 0.25-µL 0.2-M (50 nmol) MnCl2 (Fig. 2 – 5B) as previously reported [13]. In
contrast, we failed to see a detectable T1W enhancement in the visual pathway using the other
reported dosage [13], 0.125-µL 0.2-M MnCl2, (25 nmol; data not shown). In the 50 nmol dosage
group, histological analysis of retina using H&E staining showed slight cell swelling at 4 hours,
which recovered at 24 hours post-injection (Fig. 2 – 5C and 2 – 5D).
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Figure 2 – 5 The effect of intravitreal Mn2+ injection on retinal integrity and visual function was
examined on mouse eyes receiving 0.25 and 2 µL saline injection. The effect of injecting 0.25
and 2 µL on the visual acuity (VA) was examined where 2µL saline injection transiently
impaired visual function at 4 hours and Day1 after injection, subsequently recovered (VA ≥ 0.3)
at Day 2 (A). The injection of 0.25µL of saline did not impact VA (A). Representative T1W
images (B) obtained at 24 hours post-injection with the working dosage (0.25µL and 0.2M
MnCl2, 50 nmol) demonstrate the effect of Mn2+- induced intensity enhancement in the loaded
visual pathway (left retina, left optic nerve, right LGN, and right SC). The VA was affected by
the working dosage at 4 hours post-injection with nearly full recovery by 24 hours post-injection
(A). Retinal thickness was examined with H&E staining of frozen-embedded mouse eyes (C and
D). The previously reported safe intravitreal 2 µL saline injection caused retinal swelling at Day
2. In contrast, the other reported safe intravitreal saline injection (0.25 µL) indeed did not cause
any retinal swelling of the injected eyes (C and D). MnCl2 injection caused slight retinal swelling
at 4 hours that recovered at 24 hours post-injection. Histologically-revealed retinal thickening
paralleled the decreased VA caused by injection volume and Mn2+ (A).
Diamond symbols: mean value
Scale bar: 100 µm
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2.4 Discussion
This study investigated the toxicity of noninvasive topical Mn2+ loading using functional
(VA) and structural (MR) measurements followed by histological validation. Our findings show
that topical MnCl2 loading caused photoreceptor layers degeneration without detectable damage
to the optic nerve within the 7-day timecourse of this investigation. In addition, we also
investigated the impact of literature-reported safe dose of intravitreal MnCl2 injection concluding
that intravitreal injection causes insignificant visual impairment and is probably safer for
MEMRI studies than the newly proposed topical loading.
2.4.1 Topical loading
The route of Mn2+ entry is believed to start from the conjunctiva passing through the
ciliary body [29, 30]. Afterwards, Mn2+ may diffuse into the choroid vasculature passing through
the blood-retinal barrier [31] to enter the retinal layers. In addition, Mn2+ may also pass through
blood-aqueous barrier diffusing into vitreous space reaching the retina ganglion cell layer [32,
29]. In our hands, topical loading only resulted in anterior chamber and retina enhancement
while the vitreous space was not enhanced. This is consistent with findings by Sun et al.
reporting no intravitreal enhancement [17]. Although a definitive conclusion may not be
established from the current study, the observed lack of vitreous enhancement as well as the
preferential photoreceptor layer injury after topical loading suggests that Mn2+ may enter the
ocular space primarily through non-corneal permeation across the conjunctiva and sclera into the
anterior uvea.
Visual acuity (VA) reflects the visual function and ocular integrity of retinal efferent
pathways to subcortical visual structures [21]. In the present study, VA was employed to assess
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the effect of Mn2+ loading since VA of normal mice has been measured consistently [20]. Our
VA measurements from thirty female C57BL/6 mice were in agreement with Prusky’s finding
with less than 10% co-variance (0.37 ± 0.03 c/d; mean ± SD; n = 30). The acute 73% decrease
in VA after 0.75 M MnCl2 loading followed by a slow recovery and the total loss of vision after
1 M MnCl2 loading without recovery (throughout the course of experiment) suggests that topical
loading adversely affects visual function of the loaded eye as a result of Mn2+ toxicity since there
was no VA change after topical saline loading.
With 1M MnCl2 topical loading, the retina thickened at 1 day followed by significant
thinning at 7 days after loading [(~31%, p < 0.005); Fig. 2 – 4E and 2 – 4F]. Retinal thickening
at 24 hours after 1M MnCl2 loading appears to result from cell swelling [33, 19], while
subsequently decreased retinal thickness is likely the result of may be related to retinal
degeneration and tissue loss. There was a negligible retinal thickness change by 0.75M topical
loading (Fig. 2 – 4F). The increased image intensity of choroid (Fig. 2 – 4D) probably resulted
from manganese accumulation in endothelial cells [34].
Photoreceptor layer degeneration was seen in H & E staining (Fig. 2 – 4E), suggesting
that the entry of excess calcium analog, Mn2+, could cause metabolic dysfunction and eventual
photoreceptor cell loss [14]. At day 1 with 1-M MnCl2 loading, retina thickened variably (Fig. 2
– 4E) due to differential uptake of topically loaded Mn2+ between mice. Our T2W images
exhibited strong vitreous signal intensities (Fig. 2 – 3A ~ 2 – 3D), potentially confounding layer
thickness estimation although retinal swelling and thinning was clearly visible in T2W images. A
balanced steady state free precession (bSSFP) MR sequence has been demonstrated to be timeefficient to detect retinal layer and layer-specific responses to hypoxia in retinal and choroidal
vasculature, which are separated by an avascular region [35]. This approach could be used to
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overcome the shortcoming of T2W measurement employed herein to better assess retinal
thickness. The optic nerve integrity was examined using in vivo DTI followed by
immunohistochemistry (Fig. 2 – 3B and 2 – 3C). Normal axial (||) and radial () diffusivities
after MnCl2 loading suggest axonal integrity of the loaded optic nerve [26]. Postmortem
immunohistochemistry findings supported the conclusions drawn from in vivo DTI
measurements. There was no detectable injury in either RGC layer (Fig. 2 – 4E) or optic nerve
(Fig. 2 – 3B and 2 – 3C). The visual function impairment is more pronounced with increasing
retinal morphological distortions—initially retinal swelling (Fig. 2 – 2, 2 – 4E and 2 – 4F) and
subsequently photoreceptor loss and thinning of the retina. Topical saline loading did not cause
retinal thickness change, or VA impairment. The results suggest that Mn2+ was the primary
cause of the decreased VA and reduced retinal thickness.
2.4.2 Intravitreal injection
Intravitreal injection of MnCl2 is a common practice for MEMRI studies. Published
reports have examined toxicity of intravitreal injection of MnCl2 in mice and rats [13-15, 36].
Bearer et al. used visual evoke potential (VEP) to assess visual function [13] reporting that 0.5µL
of saline injection affected VEP response. They suggested a 0.25µL injection of 200mM MnCl2
(equivalent of 50 nmol) to be the safe dose for MEMRI studies in C57BL/6 mice. Haenold et al.
measured VA to determine visual function suggesting that 2µL of 0.0075M MnCl2 (equal to 15
nmol) as the safe dose for the same mouse strain [14]. They found that 50 nmol caused
photoreceptor degeneration with RGC injury observed at a dose over 50 nmol.
The volume of the vitreous space in C57BL/6 mice is approximately 5 µL. Chen et al.
have previously reported that 0.5 µL of intravitreal saline injection was safe [19]. Haenold et al.
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reported normal VA two days after 2 µL of saline injection [14]. The current finding saw
transient impairment of VA with 2 µL of saline injection (Fig. 2 – 5A). The recovery of VA 2
days after injecting 2 µL of saline was in agreement with that seen by Haenold et al. A
significant retinal swelling was observed with 2 µL saline injection in the present study (Fig. 2 –
5C and 2 – 5D) while 0.25µL saline injection did not impact VA (Fig. 2 – 5A) or retinal
thickness (Fig. 2 – 5C and 2 – 5D) at any time point. Our findings support the conclusion of
Bearer et al. suggesting the optimum dose for intravitreal injection is 0.25 µL of 200 mM MnCl2.
We failed to see enhancement using the dose proposed by Bearer et al., 0.125 µL of 200 mM
MnCl2 (data not shown).
In conclusion, we found that both topical loading and intravitreal injection of MnCl2
provided similar T1W enhancement in the visual system for assessing anterograde axonal
transport. Despite the non-invasive nature of MnCl2 loading, topical loading significantly
impaired VA. The photoreceptor layer was significantly injured with retinal ganglion cells
largely unaffected thus no detectable injury in the optic nerve. The working concentration of
0.75 M MnCl2 offers sufficient enhancement for assessing axonal transport. However, the visual
function was still affected at this dose thus cautioning functional correlation studies using topical
loading. In contrast, the previously reported safe dose for intravitreal injection proposed by
Bearer et al. is ideal for axonal transport correlating with functional assessment in mouse visual
system.
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Chapter 3
Axonal transport rate decreased at the onset of optic neuritis in EAE mice
This chapter represents a manuscript initially submitted on August 16th to The Journal of
Neuroscience and currently under review.
(Tsen-Hsuan Lin, Joong Hee Kim, Carlos Perez-Torres, Chia-Wen Chiang, Kathryn Trinkaus,
Anne H. Cross, and Sheng-Kwei Song)
Abstract
Optic neuritis is frequently the first symptom of multiple sclerosis (MS), an inflammatory
demyelinating neurodegenerative disease. Impaired axonal transport has been considered as an
early event of neurodegenerative diseases. However, few studies have assessed the integrity of
axonal transport in MS or its animal models. In this study, we employed manganese-enhanced
MRI (MEMRI) to assess axonal transport in optic nerves in experimental autoimmune
encephalomyelitis (EAE) mice, at the onset of optic neuritis. Axonal transport was assessed as (a)
optic nerve Mn2+ accumulation rate (in % signal change/hour) by measuring the rate of increased
total optic nerve signal enhancement, and (b) Mn2+ transport rate (in mm/hour) by measuring the
rate of change in optic nerve length enhanced by Mn2+. Compared to sham-treated healthy mice,
Mn2+ accumulation rate was significantly decreased by 19% and 38% for EAE mice with
moderate and severe optic neuritis, respectively. The axonal transport rate of Mn2+ was
significantly decreased by 43% and 65% for EAE mice with moderate and severe optic neuritis,
respectively. The degree of axonal transport deficit correlated with the extent of impaired visual
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function, as well as the severity of inflammation, demyelination, and axonal injury at the onset of
optic neuritis.
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3.1 Introduction
Multiple sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous
system (CNS) causing significant neurological dysfunction that accumulates over a lifetime[1].
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of MS
exhibiting many MS-like neurological dysfunctions including optic neuritis (ON) [2, 3], which is
often an early symptom of MS [4-7]. Inflammatory demyelination and axonal injury in the optic
nerve that are commonly seen in MS patients are also frequently present in EAE-affected mice
(EAE mice) [8-10]. Accumulation of amyloid precursor protein (APP) is regarded as an early
marker of axonal injury in MS patients and EAE mice [11-16]. Interruption of axonal transport in
injured axons results in the accumulation of APP, which can be detected by
immunohistochemistry (IHC) [11, 17]. Hence, axonal transport disruption is believed to be an
early event in EAE and in some patients with MS.
Magnetic resonance imaging (MRI) has played crucial roles in examining pathologies of
the optic nerve in rodent EAE [18-21]. Diffusion tensor imaging (DTI) can specifically reflect
pathologies of axon injury and demyelination in optic nerve [8, 22, 23]. Visual function tests to
assess optic nerve integrity are readily available in both human and animal models [23-25]. Thus,
the optic nerve provides an ideal system to investigate the interrelationship between white-matter
pathologies and functional outcomes. Manganese-enhanced MRI (MEMRI) has been applied in
the rodent CNS [26-30] to investigate ion homeostasis and axonal transport. Manganese ion
(Mn2+), as a calcium analogue, is taken up by neurons through voltage-gated Ca2+ channels. In
the mouse visual system, Mn2+ is taken up by retinal ganglion cells, packaged in vesicles, and
transported along microtubules down the axonal tract [31]. Mn2+, a paramagnetic ion, reduces
tissue water T1 relaxation time and its presence in tissues can be identified as hyper-intensities in
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the T1W image [32]. Therefore, Mn2+ can serve as both a contrast agent and an axonal transport
tracer.
In this study, MnCl2 was injected in the vitreous of sham and EAE mouse eyes
immediately followed by serial 3D-T1W images for 5.5 hours to quantify the axonal transport
rate. Our results suggest that axonal transport impairment is present at the onset of optic neuritis
in EAE mice, and correlates with impaired visual function and the underlying pathologies.

3.2 Materials and Methods
All experimental procedures involving animals were approved by Washington
University’s Animal Studies Committee and conformed to the Public Health Service Policy on
Humane Care and Use of Laboratory Animals (http://grants.nih.gov/grants/olaw/olaw.htm).
3.2.1 Experimental autoimmune encephalomyelitis (EAE)
Sixteen 7-week old C57BL/6 mice were obtained from Jackson Laboratory (Bar Harbor,
ME). Before immunization, mice were housed with 12-hour dark/light cycle for a week. Ten
mice were randomly selected to be immunized with 50 µg MOG35-55 peptide emulsified (1:1) in
incomplete Freund’s adjuvant (IFA) and Mycobacterium tuberculosis. Pertussis toxin (300 ng;
PTX, List Laboratories, Campbell, CA) was injected intravenously on the day of MOG35-55
immunization and two days later. The remaining six sham mice underwent the same
immunization procedure with only IFA without MOG35-55. Mice were assessed daily for
neurological disabilities using a standard clinical score [33] system: 1 = limp tail; 2 = hind limb
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weakness sufficient to impair righting; 3 = one limb paralyzed; 4 = two limbs paralyzed; 5 = 3 or
more limbs paralyzed or the animal is moribund (mice were euthanized if they reach grade 5).
3.2.2 Visual acuity (VA)
The VA of mice was measured daily starting before immunization using the Virtual
Optometry System (Optomotry, Cerebral Mechanics, Inc., Canada). Briefly, the virtual rotating
columns were projected on the LCD monitors with different spatial frequencies in cycles/degree
(c/d). The mouse head movement in response to the virtual column rotations was noted. The
spatial frequency was increased starting from 0.1 c/d with step size of 0.05 c/d until the mouse
stopped responding. The VA was defined as the highest spatial frequency of the virtual rotating
columns to which the mouse was able to respond. We have previously reported that VA of
normal C57BL/6 mice to be 0.38 ± 0.03 c/d (mean ± S.D., n=30) and defined VA ≤ 0.25 c/d as
the onset of acute ON for EAE mice [34]. MEMRI was performed on the day when mice
exhibited VA ≤ 0.25 c/d. The mice in sham group did not develop impaired visual function and
underwent the same MEMRI procedure at the same time period as EAE group.
3.2.3 Intravitreal MnCl2 injection
MnCl2 was injected in the eye that had a measured VA ≤ 0.25 c/d. Mice were
anesthetized using 1.5-2% isoflurane/oxygen. After the appropriate level of anesthesia was
achieved, assessed by the lack of response to toe pinch, mice were placed on a custom-made
head holder. A 34-gauge needle, connected to a micro-injection pump (WPI Instrument, FL, US),
was inserted into the posterior vitreous at 1-1.3 mm posterior to limbus. A dose of 50 nmol
MnCl2, given as 0.25 µL of 0.2 M solution [27], was delivered at a rate of 3 µL/min. At the
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conclusion of injection, the needle was left in the place for an extra 1 minute before withdrawal
and then a drop of antibiotic gel was applied to both injected and un-injected eyes[35].
3.2.4 Manganese-enhanced MRI (MEMRI)
MEMRI was performed immediately after MnCl2 administration on a 4.7 T Agilent
DirectDrive small-animal MRI system (Agilent Technologies, Santa Clara, CA) equipped with
Magnex/Agilent HD image gradient coil (Magnex, Oxford, UK) with pulse gradient strength up
to 58 G/cm and a gradient rise time ≤ 295 μs. Mice were anesthetized by 1.5% isoflurane/oxygen.
During experiments, respiratory rate and body temperature were monitored using a MR
compatible animal monitoring system (SA Instrument, Inc., Stony Brook, NY, US) and
maintained at 130 – 150 breaths/min and 37˚C with a regulated circulating warm water pad
underneath mouse body along with regulated warm air blown into the magnet bore, respectively.
A pair of 8-cm diameter volume (transmit) and 1.7-cm diameter surface (receive) activedecoupled coils were used.
A standard 3D gradient echo sequence was employed for T1-weighted (T1W) image of
the whole mouse brain with the following parameters: repetition time (TR) = 15 ms, echo time
(TE) = 2.63 ms, flip angle = 20˚, number of averages = 16, field-of-view (FOV) = 15 × 15 × 22
mm3, matrix size = 128 × 128 × 64 (zero-filled to 256 × 256 × 128), acquisition time = 32.8
minutes. Ten successive sets of 3D-T1W image were captured approximately from 0.55 – 5.5
hours post-injection.
3.2.5 B1-inhomogeneity correction
A 3D-T1W image of a phantom (uniform 13 × 9 × 25 mm3 of 2% agar gel placed
underneath the active-decoupled surface coil with the distance between gel and coil similar to the
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in vivo study) was acquired using the same MEMRI parameters with 64 averages to obtain the
profile of surface coil sensitivity (acquisition time was 131.2 minutes). To correct B1
inhomogeneity, the raw 3D-T1W image of the mouse brain was divided by the 3D-T1W image
of 2% agar phantom voxel by voxel directly using image calculator in ImageJ [36] and the
corrected 3D-T1W image data set was generated for analyzing MEMRI data.
3.2.6 MEMRI data analysis
Surface-coil sensitivity profile corrected T1W image data set of the final time point was
displayed using volume viewer plugin version 1.31 in ImageJ
(http://rsbweb.nih.gov/ij/plugins/volume-viewer.html, NIH, US) with z-aspect factor of 2
resulting in isotropic 256 × 256 × 256 data matrix. The 3D data matrix was adjusted by rotating
about x- and z-axis and distance slider to make oblique image plan bisecting both optic nerves.
The oblique image containing both nerves was saved and converted to 8-bit gray scale. The
corrected 3D-T1W image data sets of other previous time points were rotated using the same
rotation parameters. The final result was a stack of oblique corrected T1W images (ten images)
from each mouse (from 0.55 – 5.5 hours post-injection) for accumulation and transport rate
calculation.
To derive the rate of total Mn2+ accumulation, ROI of optic nerves were drawn on the
oblique corrected T1W image at the final time point for each mouse. The average size of the
optic nerve ROI was 188 ± 27 voxels (n=160, mean ± S.D.). A 20 × 20-voxel reference area ROI
was drawn 30 voxels away from optic nerve head. This reference area ROI was pure muscle, not
affected by Mn2+. The ROI information of optic nerves and reference area was saved and then
applied to oblique corrected T1W images of other previous time points. Finally, the
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normalization was performed by taking the ratio of signal intensity of optic nerve ROIs and their
respective reference ROI.
To calculate Mn2+ transport rate, a line ROI was drawn along the signal-enhanced and the
contralateral optic nerves at the final time point, taking advantage of the increased contrast for
the ROI definition. The same line ROIs were applied to the corrected T1W images at all time
points. The average size of Mn2+-loaded and reference line ROI was 54 ± 3.3 and 53 ± 3.2 voxels
(n = 160, mean ± S.D.) respectively. The arrival of Mn2+ at the loaded nerve was defined by
counting voxels with the signal intensity ≥ mean + 2 S.D. of the signal intensity of all voxels in
the contralateral optic nerve. After determining the number of voxels in the length of Mn2+enhanced optic nerves was converted to millimeter by combining the known in-plane image
resolution, the geometric transformation associated with the oblique slice plane and the
Pythagorean equation [37]. Transport rate was defined as the slope of Mn2+-enhanced length
over time by linear fitting.
3.2.7 Immunohistochemistry (IHC) of optic nerves
Following MEMRI experiments, mice underwent intra-cardiac perfusion with 1%
phosphate buffered saline (PBS) followed by 4% paraformaldehyde in 0.01 M PBS. Brains were
excised and post-fixed in the same fixative for 24 hours then transferred to 0.01 M PBS for
storage at 4 ˚C until histological analysis was performed. Mouse optic nerves were dissected
from each brain and embedded in 2% agar blocks [38]. Then, the agar blocks were embedded in
paraffin wax and 5-µm thick transverse slices were sectioned for IHC staining. Sectioned slices
were deparaffinized, and rehydrated to facilitate binding of antibodies and then blocked using
solution mixed with 1% bovine serum albumin (BSA, Sigma-Aldrich, MO, USA) and 5%
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normal goat-serum solution (Invitrogen, CA, USA) for 20 minutes at room temperature to
prevent non-specific binding and to increased antibody permeability. Slides were incubated with
monoclonal anti-phosphorylated neurofilament antibody (SMI-31; 1:1000, Covance, NJ, USA)
to stain non-injured axons, or with rabbit anti-myelin basic protein antibody (MBP, 1:1000,
Sigma-Aldrich, MO, USA) to stain myelin sheath [8, 39, 40] at 4˚C overnight. After rinsing, goat
anti-mouse IgG or goat anti-rabbit IgG conjugated Alexa 488 (1:800, Invitrogen, CA, USA) were
applied to visualize immunoreactivity of phosphorylated neurofilaments and MBP. Finally,
slides were covered using Vectashield Mounting Medium with 4’,6-diamidino-2-phenylindole
(DAPI) (Vector Laboratory, CA, USA) to stain nuclei [40, 41]. Histological slides were
examined with Nikon Eclipse 80i fluorescence microscope equipped with a 60× water objective,
and images were captured with a black-and-white CCD camera using MetaMorph software
(Universal Imaging Corporation, Sunnyvale, CA, USA) at the center of optic nerve.
3.2.8 Histological data analysis
The whole field of SMI-31, MBP, and DAPI staining images at 60× magnification were
captured with the same fluorescence light intensity and exposure time. All captured images were
converted to 8- bit gray scale and analyzed using threshold, analyze particles and gray level
watershed segmentation functions in ImageJ (http://bigwww.epfl.ch/sage/soft/watershed/).
3.2.9 Statistical analysis
Linear repeated measures models were used to test normalized Mn2+-enhancement signal
intensities at each time point (from 0.55 – 5.5 hours post-injection with 0.55-hour step size) for
pairwise comparison among shame and EAE mice with moderate and severe ON: sham vs.
moderate, sham vs. severe, and moderate vs. severe groups.
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Multiple comparisons for accumulation rate, transport rate, SMI-31, MBP, and DAPI by
each study group (sham/moderate/severe) were performed using a linear regression model of
each outcome. P-values for the three pairwise tests (sham vs. moderate, sham vs. severe, and
moderate vs. severe) were adjusted using Tukey’s HSD (honest significant difference). VA,
SMI-31, MBP and DAPI were measured once per mouse and their association with the rate of
change in accumulation or transport was analyzed using Spearman rank correlation coefficients.

3.3 Results
3.3.1 Visual acuity
After immunization, daily visual acuity (VA) of sham and EAE mice was measured.
When mice exhibited VA ≤ 0.25 c/d [34], MEMRI was performed (12 ± 2.1 days postimmunization, mean ± S.D., n=10). In this study, CS appeared at the same day as the first sign of
impaired VA. VA at ON onset was different among mice examined and was used to separate
mice into three groups: sham (VA = 0.35 or 0.4 c/d; CS = 0), moderate ON (VA = 0.2, CS = 1
for one mouse; VA = 0.25 c/d, CS = 0 for the other four mice), and severe ON (VA = 0 c/d, CS
=0 for two mice and CS = 2.5 for the other three mice in this group; Fig. 1 A).
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Figure 3 – 1 Group averaged visual acuity (VA) of sham (n=6) and EAE (n=10) eyes before
MEMRI experiments. EAE mice were separated based on VA to moderate (VA = 0.25/0.20 c/d)
and severe (VA = 0 c/d) ON groups (A). A serial time-lapse oblique corrected T1W images from
representative mice are presented to demonstrate the different degree of Mn2+-enhancement of
optic nerves from sham and EAE mice from 1.1 – 5.5 hours post-injection (B). Mn2+enhancement of optic nerves clearly increases with time. At the end time point, mice with the
lower VA exhibited less Mn2+-enhancement reflecting slower axonal transport.
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3.3.2 The optic nerve Mn2+ accumulation rate
Since the image intensity was used to detect Mn2+ arrival, the B1-inhomogeneity
correction of the surface coil was performed (Lin et al., 2003, Hou, 2006) using the 3D T1W
image of 2% agar gel. After correction, the averaged intensity of randomly selected line profiles
on the corrected T1W images was comparable in both vertical and horizontal directions
suggesting a reasonable B1-field inhomogeneity correction (data not shown).
A series of time-lapse representative B1-profile corrected oblique T1W images of sham,
moderate and severe ON mice exhibited different degrees of Mn2+-enhancement suggesting
different axonal transport rates in optic nerves. The hyper-intensity of optic nerve resulting from
axonal transport of Mn2+ was readily visible (Fig. 1 B). The optic-nerve and reference ROI were
defined (Fig. 2 A). The time course of group averaged signal intensity ratios of optic-nerve to
reference ROI exhibited different rate of signal enhancement among the sham and EAE mice
with moderate and severe ON (Fig. 2 B). The accumulation rate of Mn2+ in the optic nerve was
defined as the slope of the linear fit of the data over time. The group averaged optic nerve Mn2+
accumulation rate (the slopes) of sham, moderate ON, and severe ON mice was 0.16, 0.13, and
0.10 a.u./hour, respectively (Table 1; Fig. 2C). The accumulation rate in EAE mice was
significantly slower than that of the sham by 19% (moderate ON, p < 0.005), and 38% (severe
ON, p < 0.005). The accumulation rate was 23% (p < 0.05) slower in the EAE mice with severe
ON than that with the moderate ON. The accumulation rate correlated with VA (r = 0.87, p <
0.0001).
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Figure 3 – 2 The ROI of optic nerve and reference area of muscle, where Mn2+ does not reach,
were defined on the corrected T1W oblique image at each time point (A). The group average of
the normalized optic nerve signal intensity from sham, moderate ON and severe ON mice was
obtained for each time point from 0.55 – 5.5 hours after injection at a 0.55 hours resolution. The
higher rate of Mn2+ accumulation over time was associated with the better VA (B). The group
averaged slope of the normalized signal intensity over time was defined as the optic nerve
accumulation rate of total Mn2+. The box plots reveal that Mn2+accumulation rate of severe ON
optic nerves was slower than that of the moderate ON nerves, which was slower than that of the
same nerves (B and C).
* indicates p < 0.05
** indicates p < 0.005
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3.3.3 Transport rate of Mn2+
The Mn2+-loaded and contralateral optic nerve reference line ROIs were defined (Fig. 3
A). The enhanced T1W intensity of the optic nerve after Mn2+ loading was readily discernible
after the subtraction of mean line ROI intensity of the reference optic nerve (Fig. 3 B – D).
Representative difference images of sham and EAE mice with moderate ON exhibited different
length of the Mn2+-enhanced optic nerve. The entire optic nerve was enhanced at 3.3 and 5.5
hours post-injection for sham (Fig. 3 B) and EAE mice with moderate ON (Fig. 3 C),
respectively. In EAE mice with severe ON, only partially enhanced optic nerve was seen (Fig. 3
D). The time course suggested that the group-averaged time to enhance the entire optic nerve
took 3.3 and 4.95 hours for sham and EAE mice with moderate ON, respectively (Fig. 3 E). The
slope of each group represents the transport rate (% of optic nerve/hour). The group averaged
Mn2+ transport rate of sham, moderate ON, and severe ON mice was 26, 14, and 8 % of optic
nerve/hour (Fig. 3 E). The Mn2+ transport rate converted to mm/hour was: 0.92, 0.52, and 0.32
mm/hour for the sham, moderate ON, and severe ON mice, respectively (Table 1). The transport
rate of EAE mice was decreased compared with sham mice by 43% (p < 0.05) and 65% (p <
0.005) respectively for moderate and severe ON groups. EAE mice with moderate ON exhibited
a non-significant trend of faster transport rate than severe ON mice (p = 0.15). The transport rate
correlated well with the VA (r = 0.85, p <0.0001).
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Figure 3 – 3 To estimate Mn2+ transport rate in mm/hour, line-ROIs were defined to match the
optic nerve length (A). The arrival of Mn2+ in optic nerves was defined by the T1W enhancement
of the optic nerves referencing to the line-ROI of the non-loaded eye. To visualize the extent of
Mn2+-enhancement, representative oblique-corrected T1W images from each group were
displayed after subtracting the mean intensity of the reference line-ROI (B, C, and D). Three
representative subtracted images of sham, moderate ON and severe ON mice (VA = 0.4, 0.25,
and 0, respectively) show different degree of Mn2+ transport at 1.1, 3.3, and 5.5 hours postinjection (B, C, and D). For quantification of the transport rate, the arrival of Mn2+ was
determined using non-subtracted images at each time point by identifying line-ROI voxels of the
loaded eye with intensity higher than two standard deviation of the mean from the reference lineROI of the non-loaded eye. The group averaged displacements, normalized to the total number of
voxels of each nerve (red line, panel E), of Mn2+ over time revealed different rate of Mn2+
transport among the three groups of mice examined (E). Box plot shows transport rate
distribution of each group in mm/hour by converting normalized voxel displacement to mm (F).
The results demonstrated that Mn2+ transport rate of sham optic nerves were significantly faster
than moderated ON (p < 0.005) and severe ON (p < 0.005) suggesting the presence of axonal
transport impairment at the onset of ON in EAE mice.
* indicates p < 0.05
** indicates p < 0.005
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Table 3 – 1

Group averaged accumulation and transport rates of sham (n=6), moderate ON (n=5)
and severe ON (n=5)
Sham
(n=6)

Moderate ON
(n=5)

Moderate ON
(n=5)

Accumulation Rate

0.16 ± 0.01

0.13 ± 0.01

0.10 ± 0.02

Transport Rate

0.92 ± 0.14

0.52 ± 0.17

0.32 ± 0.21

Accumulation Rate (a.u./hour): mean ± S.D.
Transport Rate (mm/hour): mean ± S.D.
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3.3.4 Immunohistochemistry (IHC) of optic nerve
Post-image SMI-31, MBP, and DAPI staining of optic nerves from sham and EAE mice
with moderate and severe ON was used to assess the integrity of axons and myelin sheaths, and
the extent of cellularity (Fig. 4A). Diminished SMI-31 positive axon density suggested axonal
injury in EAE mice with moderate and severe ON. Myelin damage of EAE optic nerves was also
evident by the decreased density of MBP positive axons. Increased number of DAPI positive
nuclei in EAE optic nerves was observed, consistent with cellular inflammation (Fig. 4 A). The
SMI-31 positive axon counting showed a significantly diminished intact axon density in optic
nerves from EAE mice with moderate (5.6 ± 0.5 × 105, p < 0.005, Fig. 4 B) and severe (4.5 ± 0.9
× 105, p < 0.005, Fig. 4 B) ON. The significant loss of MBP positive axons expressed as area
fraction in optic nerves with moderate (41.6 ± 2.0 %, p < 0.05, Fig. 4 B) and severe (34.0 ± 3.4
%, p < 0.005, Fig. 4 B) ON was also observed compared with the sham group (48.3 ± 3.9 %).
DAPI positive cell nuclear staining was significantly increased in optic nerves from mice with
severe ON (9.1 ± 3.3 × 103) when compared with the sham (3.9 ± 0.6 × 103, p < 0.005, Fig. 4B)
and moderate ON (5.4 ± 1.0 × 103, p < 0.05, Fig. 4B) mice. However, the difference between
sham (3.9 ± 0.6 × 103) and mice with moderate ON (5.4 ± 1.0 × 103, p = 0.1, B) was not
significant. Visual function (measured by VA) highly correlated with SMI-31 (r = 0.84, p <
0.0001), MBP (r = 0.88, p < 0.0001), and DAPI (r = -0.81, p = 0.0002). The Mn2+ accumulation
and transport rate correlated well with the extent of axonal injury (r = 0.85 and r = 0.86,
respectively, p < 0.0001) assessed by the density of SMI-31 positive axons, myelin injury (r =
0.91 and r = 0.82, respectively, p < 0.0001) assessed by the MBP positive axons, and
inflammation (r = -0.83 and r = -0.84, respectively) assessed by the density of DAPI-positive
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nuclear staining (Fig. 5A – F). Moreover, total amount of Mn2+ accumulation rate correlated well
with Mn2+ transport rate (r = 0.78, p = 0.0003, Fig. 5G).
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Figure 3 – 4 Representative immunohistochemical staining of optic nerves from sham, moderate
ON and severe ON mice (A). Images displayed are 56% field-of-view from the 60×
magnification of phosphorylated neurofilament (SMI-31, green), myelin basic protein (MBP,
red), and 4’, 6-dianidino-2-phenylindole (DAPI, blue). Reduced density of SMI-31 positive
axons was seen in optic nerve from moderate and severe ON mice. Increased number of SMI-31
positive areas, may reflect axonal beading or debris (A, yellow arrows), were observed with
increased severity of VA. Decreased density of MBP positive axons was also seen with increased
VA impairment. The increased DAPI positive nuclear staining was seen with increased VA
impairment. Box plots demonstrate the difference in axonal pathologies among the three groups
examined (B).

Scale Bar: 25 μm
*p < 0.05
**p < 0.005
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Table 3 – 2

Quantitative immunohistochemistry results of sham (n=6), moderate ON (n=5) and
severe ON (n=5)
SMI-31
(#/mm2)

MBP
(Area %)

DAPI
(#/mm2)

Sham (n=6)

7.2 (± 0.5) × 105

48.3 ± 3.7

3.9 (± 0.6) × 103

Moderate ON (n=5)

5.6 (± 0.5) × 105

41.7 ± 2.0

5.4 (± 1.0) × 103

Severe ON (n=5)

4.5 (± 0.9) × 105

34.0 ± 3.4

9.1 (± 0.3) × 103

Area % of MBP: comparing to entire 60× image (0.017 mm2)
Counts: mean ± S.D.
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Figure 3 – 5 The scatter plots of axonal transport, assessed in accumulation rate (A – C) or
transport rate (D – F). Results suggested that impaired axonal transport correlated with the
severity of axonal injury, demyelination, and inflammation respectively. Accumulation rate
correlated with transport rate suggesting both reflecting axonal transport in optic nerve of EAE
(G).
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3.4 Discussion
In this study, we measured the visual function by optokinetic response (to reflect VA; Fig.
1A) and correlated it with axonal transport of optic nerves quantitated using MEMRI at optic
neuritis onset during mouse EAE (Fig. 1B). The rate of Mn2+ transport in EAE-affected optic
nerves was significantly impaired (Fig. 1 – 3) indicating defective fast axonal transport at the
onset of ON [42]. Immunohistochemistry of these tissues also indicated the presence of
demyelination, inflammation, and axonal injury in optic nerves with ON (Fig. 4B). Each of these
axonal pathologies correlated well with decreased axonal transport rate.
The rate of axonal Mn2+ accumulation has been reported to reflect axonal transport in
mice [43-46]. In the literature, a linear fit of the MEMRI data over a short time course (< 1 hour)
was commonly employed. In this study, a 5.5-hour time course was pursued. A linear repeated
measures model accounting for the correlation between observations over time applied to the
serial 10 measurements suggested that a linear fit was reasonable (data not shown). Thus, a more
complex modeling [26, 47] was not pursued in this study to analyze the MEMRI time course
data. In addition to this widely employed Mn2+ accumulation rate, the current study also assessed
axonal transport rate in optic nerves at the onset of ON caused by EAE. The reported fast axonal
transport rate ranges between 3 – 16 mm/hour [42, 48]. The Mn2+ transport rate by MEMRI has
been reported ranging between 0.64 – 5 mm/hour, estimated by a two-point time-lapse
measurement [27, 28, 49-53]. In the present study, the Mn2+ transport rate in sham optic nerves
was 0.92 ± 0.14 mm/hour, at the lower end of published values. Animals in the current study
were under isoflurane anesthesia throughout the course of the measurements. The lower axonal
transport rate estimated herein may result from the long period of anesthesia [54, 55]. The
transport rate estimated using data from the initial 0.55 hours was 1.33, 1.49, and 1.31 mm/hour
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in sham, moderate and severe ON groups, respectively. The higher initial rate supported the
possible effect of prolonged anesthesia on the measured transport rate. The varied rate of
transport using the initial time-lapse data immediately after injection may reflect the variable
severity of ON among mice, or the variable response of individual mice to the induction of
anesthesia, masking the transport rate difference among groups. The linear increase over time of
MEMRI length of the optic nerve between 0.55 – 5.5 hours from all groups suggested that a
steady-state of anesthesia was reached 0.55 hours after the injection of Mn2+.
The axonal Mn2+ transport rate between moderate and severe ON groups was not
statistically different (Fig. 3F). This may be due to the variation in axonal pathologies of the
severe ON group, leading to a high standard deviation in that group. It may also be due to
imprecision of the method of VA measurement [56]. Optic nerves from three EAE mice with
severe ON were not fully enhanced at the end of 5.5 hours post-injection (Fig. 3 E) while the
remaining two exhibited whole optic nerve enhancement at 4.4 and 4.95 hours. These two mice
also exhibited axonal injury (25% decrease in SMI-31 staining compared with the control)
comparable to that in the moderate ON mice (22 ± 7%). IHC results indicated that the mice with
higher transport rates suffered less axon and myelin damage than those with slower transport
rates. It is possible that acute vasogenic edema at the ON onset impeded action potential
propagation and thus reduced VA without significant axonal pathologies [18, 57].
Why might axonal transport be affected in early inflammatory demyelination? Axonal
transport depends on energy supplied by mitochondria [58]. In MS and its animal model EAE,
several pathologies conspire to reduce energy supply. Nitric oxide and the free radical/reactive
oxygen species are increased, including within axons, and inhibit mitochondrial function [59]
reducing energy production. Sodium channel redistribution in demyelinated axons reduces
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internode length, thereby increasing the energy consumption needed for signal propagation [33,
60, 61]. The potential energy deficit would eventually lead to failure of the Na+/K+-ATPase
pump (which requires energy for maintenance) and increased intracellular Na+, thus triggering
the reversal of Na+/Ca2+ exchanger. The resultant influx and accumulation of intracellular Ca2+
may then lead to further mitochondrial dysfunction and axonal damage [62-66]. Excessive
glutamate production by inflammatory cells, coupled with reduced buffering capacity of glial
cells leads to glutamate-induced excitotoxicity of axons (which express glutamate receptors) in
EAE [63, 66-69], and results in inhibition of mitochondrial mobility and function [70, 71].
Therefore, a vicious cycle of disruption of ion homeostasis, energy deficits, and axonal transport
deficits could play a crucial role in axonal degeneration [42, 48, 64, 72].
Since APP is a post-mortem biomarker as early axonal transport disruption and indicates
axonal injury, we speculate axonal transport disruption is an early event of axonal pathologies.
Although the current data are not sufficient to determine whether the impaired axonal transport is
the result or the cause of axonal injury at the onset of ON, its association with various axonal
pathologies has been reported. Excess nitric oxide and reactive oxygen species are produced
during neuroinflammation. These species have been shown to decrease axonal transport in vitro
[73, 74]. In other studies, excessive nitric oxide was shown to reversibly block impulse
conduction in demyelinated CNS axons of rodents [75] while reduction in nitric oxide at the
inflammation site prevented further axonal degeneration [76]. Demyelination was also reported
to result in axonal transport disruption in EAE mice [77, 78]. Phosphorylated neurofilaments
play a role in regulating axonal transport [79, 80]. Our current findings that decreased axonal
transport correlated with reduced SMI-31 (marker of phosphorylated neurofilaments) and MBP
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(marker of myelination), and increased DAPI staining (marker of cell nuclei that is increased
during inflammation) are consistent with these literature reports.
In summary, this study revealed the presence of impaired optic nerve in vivo axonal
transport in the early stages of ON in EAE mice. The degree of decrease of the axonal transport
rate correlated with severity of impaired visual function, and axonal pathologies including axonal
injury, demyelination, and inflammation. Preventing and improving the early axonal transport
deficit may be a potential treatment target to halt the degeneration of axons in MS. We have
demonstrated the feasibility of quantitatively assessing axonal transport in EAE mice, suitable
for a future pre-clinical drug development targeting axonal transport. Measuring axonal transport
using MEMRI would not be a viable option in humans due to the potential toxicity of Mn2+.
However, preventing axonal degeneration by targeting axonal transport may be assessed by
using axonal integrity as the outcome measure monitored using techniques such as diffusion
MRI.
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Chapter 4
White-Matter Diffusion fMRI of Mouse Optic Nerve
This chapter represents a modified version of a manuscript initially published in NeuroImage.
(William M. Spees, Tsen-Hsuan Lin, Sheng-Kwei Song White-Matter Diffusion fMRI of Mouse
Optic Nerve. NeuroImage, 2013, 65: 209-215)
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Abstract
Non-invasive assessment of white-matter functionality in the nervous system would be a
valuable basic neuroscience and clinical diagnostic tool. Using standard MRI techniques, a
visual-stimulus-induced 22% decrease in the apparent diffusion coefficient of water
perpendicular to the axonal fibers (ADC) is demonstrated for C57BL/6 mouse optic nerve in
vivo. A slight increase in ADC|| (diffusion parallel to the optic nerve fibers) was observed during
visual stimulation. The stimulus-induced changes are completely reversible. A possible vascular
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contribution was sought by carrying out the ADC measurements in hypercapnic mice with and
without visual stimulus. No differences were seen between room-air-breathing and hypercapnic
animals. The in vivo stimulus-induced ADC decreases are roughly similar to literature reports
for ex vivo rat optic nerve preparations under conditions of osmotic swelling. The experimental
results strongly suggest that osmotic after-effects of nerve impulses through the axonal fibers are
responsible for the observed ADC decrease.

104

4.1 Introduction
Currently functional MRI (fMRI) studies are limited almost exclusively to gray matter,
and rely upon coupling of hemodynamic response to functional activation [1]. Signal
modulations on the order of 1 – 5% are typical. The limited capacity for physiologic modulation
of blood flow and the inherently lower fractional blood volume probably account for the
difficulty in monitoring white-matter functional activation with standard BOLD (Blood Oxygen
Level Dependent) fMRI techniques [2, 3]. Thus, at present, white-matter MRI is largely
restricted to probing the structural integrity of fiber tracts using diffusion tensor imaging or
variants thereof [4].
Diffusion weighting has been investigated as a potential alternative to BOLD for
monitoring neuronal activity in gray matter of the human visual cortex [5]. An ~1 - 2% increase
in diffusion weighted MRI signal intensity was reported (b = 1.8 ms/m2), suggested to arise
from activity-dependent cell swelling. In a subsequent report, a similar diffusion-weighted MRI
signal intensity increase was elicited via hypercapnia-induced brain blood flow enhancement
without neuronal activation [6]. Thus, the specificity of diffusion fMRI signal change to
neuronal activity may be confounded by a sizeable vascular contribution.
In ex vivo rat optic nerve preparations, repeated electrical stimulation produces
frequency- and duration-dependent shrinkage of the extracellular space (ECS), with higher
frequencies and longer stimulus trains resulting in a more pronounced ECS reduction [7]. A
consensus has emerged that the observed ECS shrinkage results from an osmotic shift of water
into glial cells as part of a mechanism for maintaining extracellular ionic balance and neuronal
electrophysiologic competence [8-11].
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To determine the feasibility of detecting diffusion weighted MRI signal changes in white
matter responding to functional stimulation, as well as the specificity of this signal change to
axonal activation, optic nerves from room-air-breathing and hypercapnic mice were examined
with and without the application of visual stimulus.

4.2 Materials and Methods
4.2.1 Animal
All experimental procedures were in compliance with the protocol approved by the
Washington University Animal Studies Committee. Female C57BL/6 mice, aged 10 – 12 weeks,
obtained from Jackson Laboratory (Bar Harbor, ME) were used in the experiments.
4.2.2 Visual Acuity
Prior to MRI experiments, visual acuity of each mouse was measured with a Virtual
Optokinetic System (CerebralMechanics, Inc.) as previously reported [12], to ensure normal
vision.
4.2.3 Animal Monitoring
Respiratory rate and rectal temperature of anesthetized mice were monitored during
experiments using an MR-compatible animal monitoring system (Small Animal Instruments, Inc.,
Stony Brook, NY) to ensure physiologic stability. A body-core temperature of 37ºC was
maintained via a circulating warm water pad placed underneath the animal and thermostated
warm air blown into the magnet bore.
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4.2.4 Anesthesia
The anesthesia regimen employed has been shown to maintain fMRI-observable
neuronal response in mice [13]. Anesthesia was induced with 2.5% isofluorane in O2, and
reduced to 1.5% for placement of the animal in the imaging cradle. After positioning of the
animal in a head holder and achieving a stable respiratory rate, a subcutaneous 0.3 mg/kg bolus
of medetomidine was administered. Beginning three minutes after the bolus injection,
isofluorane levels were reduced by ~ 0.2% per minute until the inhaled gas consisted of 100% O2.
At 10 minutes after the bolus injection, continuous subcutaneous infusion of medetomidine was
initiated at a rate of 0.6 mg/kg/hr, and the nose cone for inhalant anesthetics was removed,
leaving the animal breathing room air for the duration of the MR experiment. In experiments
investigating the effect of hypercapnia (air vs. 5% CO2/95% O2), the animal, head holder, and
other equipment was placed in a closed plastic tube that allowed control of breathing gas
composition.
4.2.5 Magnetic Resonance Imaging
MRI experiments were performed on a 4.7-T Agilent DirectDriveTM Small-Animal MRI
system (Agilent Technologies, Santa Clara, CA), equipped with Magnex/Agilent HD imaging
gradients (Magnex/Agilent, Oxford, UK). The gradient hardware, interfaced with a set of IEC
300 A gradient power amplifiers (International Electric Company, Helsinki, Finland), is capable
of pulsed gradient strengths up to 58 G/cm with a gradient rise time ≤ 295 s. An activelydecoupled volume (transmit)/surface (receive) coil pair was used for MR excitation and signal
reception [14]. A diffusion-weighted, multi-echo spin-echo imaging sequence [15] was
employed for scout images and also for the final targeted diffusion-weighted images (Fig. 4 – 1).
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To minimize partial volume effects in optic nerve diffusion measurements, the image plan was
adjusted to ensure that, as nearly as possible, the optic nerve fibers were orthogonal to the image
slice plane (Figs. 4 – 2b and 4 – 2c). Image acquisition parameters included a slice thickness of
1.3 mm and a 20  20 mm2 (256  256) field-of-view. A sequence repetition time of 1.5 s was
employed, thus the total acquisition time for a pair of diffusion-weighted images probing a single
diffusion direction was 12.8 minutes. To increase accumulated signal-to-noise ratio for each
phase-encoding step, a train of three echoes were co-added to form the final MR images. The
first echo time (which included a pair of diffusion-weighting gradient lobes centered about the
180 refocusing pulse) was 37.1 ms, with a spacing of 23.6 ms between the first and all
subsequent echoes without diffusion gradients.
Some evidence for attenuated changes in ADC with repeated applications of visual
stimulus after the initial “on” block was seen (data not shown). This could possibly result from
accumulation of inactive forms of retinal rhodopsin during the rather lengthy 12.8-minute
stimulus block [16]. To avoid potentially confounding results, ADC and ADCǁ were measured
in separate cohorts of animals.
For each experimental condition (e.g., baseline, visual “stimulus on”, post- “stimulus off”,
etc.) a pair of diffusion-weighted images with different diffusion weightings was acquired (Fig. 4
– 2c). For the cohort in which ADC was evaluated, b values of 0.10 ms/m2 and 1.40 ms/m2
were used ( = 5 ms,  = 18 ms, Gdiff = 6 G/cm or 22.6 G/cm for a pair of trapezoidal diffusionweighting gradients). Because of the much less restricted diffusion along the axis of the optic
nerve (Fig. 4 – 3), measurements in the ADC|| cohort were made based on a pair of diffusionweighted images having b values of 0.10 ms/m2 and 0.70 ms/m2 ( and  were the same as for
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ADC measurements, but Gdiff = 6 G/cm or 15.5 G/cm). It is worth pointing out that, in the
diffusion MR literature, b values reported in units of s/mm2 are not uncommon, with ADC being
reported in mm2/s units in that case. To convert to those units, our numerical values for b should
be multiplied by 1,000 and our ADC numbers divided by 1,000.
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Figure 4 – 1 Pulse sequence diagram for the diffusion-weighted multi-spin-echo sequence.
Timing parameters include:  = 5 ms,  = 18 ms, TE = 37.1 ms TE2 = 23.6 ms.

110

Figure 4 – 2 Typical scout planning images (a,b), final targeted images for diffusion
measurements (c,d), and ADC maps of an optic nerve without (e) and with visual stimulation
(f). (a) A multi-slice set of axial images of the mouse brain is acquired with a non-diffusionweighted multi-echo spin-echo image (only a single slice is shown here) are used to plan sagittal
slices, indicated by the white lines. (b) The center sagittal slice, acquired with diffusionweighting gradients applied in the slice-select direction, captures both optic nerves (arrow) and is
used to target the slice for measurements of ADC and ADCǁ. (c) A pair of diffusion-weighted
images with diffusion-sensitizing gradients applied in the phase-encode direction (left-to-right in
the images). The optic nerve fibers are perpendicular to the slice plane in this final targeted slice.
(d) Magnified view of the area within the red box of panel c. Both optic nerves are visible with
the stimulated optic nerve indicated by the red arrow. Color maps of ADC in an experimental
optic nerve without (e) or with (f) visual stimulation.
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Figure 4 – 3 Diffusion attenuation curves for mouse optic nerve with diffusion weighting
perpendicular and parallel to the nerve fibers (without visual stimulation), acquired with ( = 5
ms,  = 18 ms). Parallel diffusivity is essentially mono-exponential. It is readily apparent that
diffusion perpendicular to the fibers is highly restricted and non-monoexponential. The blue and
red curves are constructed with ADC = 0.11 m2/ms (blue curve, representative of activated
optic nerve) and ADC = 0.16 m2/ms (red curve, representative of unstimulated optic nerve).
The estimated changes in ADC from the mono-exponential data modeling indicate an
approximately 5.7% signal increase at b = 1.4 ms/m2 with visual stimulation.
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4.2.6 Visual Stimulation
Visual stimulation was achieved by repetitive flashing of a high-intensity, white LED
(Cree, Model C503C-WAS) fixed at a position 5 cm in front of the animal’s nose and aimed at
one of the animal’s eyes. Light was blocked out of the contralateral eye with two layers of black
electrical tape. A step-function signal of 1.4 Hz frequency [17], 200 ms on/514 ms off, with
amplitude of 4 V/0 V (on/off) was provided by a Grass Instruments S9 stimulator (Grass
Technologies, West Warwick, RI). With a 100  series current-limiting resistor, the forward
voltage across the LED is 3.2V. The circuit draws 8 mA of DC current in the “on” state,
corresponding to a luminous intensity of ~ 14 candela. DC current was carried from the
stimulator (outside the magnet) through the LED (inside the RF-shielded bore of the magnet) by
a pair of coaxial BNC cables. Additionally, a pair of 3-segment LC filters was placed on each
BNC line where it fed into the magnet bore to eliminate delivery of unwanted RF interference
into the magnet. The outer conductor of each BNC line was grounded to the magnet’s RF shield
at the feedthrough into the magnet. In MRI measurements with “stimulus on”, the flashing light
stimulus was applied for the entire 12.8-minute duration of the imaging acquisition.
While white matter tends to be less well-vascularized than gray matter structures, the
vascularization of the mouse optic nerve is not negligible, with retinal venous drainage routed
within close proximity to the ROI investigated [18]. In order to determine the effect of possible
dilation of optic nerve vasculature and associated changes in blood oxygenation level on the
observed ADC decrease, “baseline” and “stimulus on” measurements were also made in
anesthetized mice breathing a mixture of 5% CO2/95% O2 (n = 5). In cases where the breathinggas composition was changed, a period of 5 minutes was allowed prior to the commencement of
MR measurements.
113

4.2.7 Data Processing and Image Segmentation
All MR images were zero-filled to 512  512 data matrices. To ensure the absence of
any possible hardware-related systematic variation in image signal, the ADC was determined in a
20  20 region-of-interest drawn within the basal forebrain (a brain region not expected to be
activated with visual stimulation, but located within a reasonable proximity to the optic nerves)
and the contralateral/control non-stimulated optic nerve from each pair of diffusion-weighted
images. The regions of interest (the optic nerves) were manually outlined on an image with b =
1.40 ms/m2 diffusion-weighting perpendicular to the optic nerve fiber direction, which provides
fairly clear definition of the optic nerves (Figs. 4 – 2c and 4 – 2d). Voxels on the outer periphery
of the optic nerve were excluded from the ROI. Optic nerve ROIs consisted of ~ 20 voxels or ~
30,000 m2 [range: 16 – 26 after zero-filling (24,000 – 40,000 m2), corresponding to 4 – 6
voxels before zero-filling), for which individual apparent diffusion coefficients were calculated.
These individual voxelwise values were pooled together for subsequent statistical analyses.
The signal intensity, S(b), in the range of b values employed for ADC|| and ADC
estimation is essentially a monoexponential decay, although the signal-decay behavior, it should
be noted, is more complex than this over a wider range of b values (Fig. 4 – 3). As is commonly
done in measurements at only two b values, the following equation (Eq. (4.1)) was employed to
estimate both ADC|| and ADC:

 Sb
ln 
  b  b   ADC .
 Sb  

(4.1)
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The contrast in parallel-diffusion-weighted images does not readily reveal the definition of the
optic nerve. For measurements of ADC||, each pair of diffusion-weighted images was preceded
and followed by a single diffusion-weighted image with diffusion gradients applied
perpendicular to the nerve fibers and b = 1.40 ms/m2. The definition of the ROI was then
prescribed referencing the images acquired with perpendicular diffusion weighting.
4.2.8 Statistical Tests
One-way ANOVA with Tukey test post-hoc means comparison was performed to assess
differences between group data (e.g., ipsilateral optic nerve: “baseline” vs. “stimulus on” vs.
“stimulus off”, contralateral optic nerve: “baseline” vs. “stimulus on”, etc.).
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4.3 Results
The imaging protocol employed provides good quality images of the mouse optic nerve.
Signal-to-noise ratio varied across the study animals in the range from 22.3 to 30.3 with low
diffusion weighting (b = 0.1 ms/m2) and 17.2 to 25.1 for higher diffusion weightings (b = 1.4
ms/m2).
In the cohort of animals for which ADC was measured (n = 5 mice), a sizeable and
statistically significant 22% decrease (p = 0.0019, Baseline vs. Stimulus On) from 0.172 ± 0.004
m2/ms to 0.134 ± 0.003 m2/ms (mean ± sem, see Fig. 4 – 4 and Table 4 – 1) was observed. In
individual animals, the range of ADC decrease with stimulation was between 10% and 34%.
The change was completely reversible with cessation of visual stimulation. In the contralateral
control optic nerve, no systematic variation in ADC was detectable with application of stimulus
to the ipsilateral eye (Fig. 4 – 4). Additionally, the ADC measurements from within the
reference basal forebrain region were quite stable with variations no more than 3% both intraand inter-subject. From the inset in Figure 4, it can be appreciated that the inter-subject variation
in ADC is then largely a result of partial volume effects as the mouse optic nerve is surrounded
by CSF which, by comparison, has a relatively high diffusivity.
A small, but still statistically significant increase (3%) in optic nerve ADC || (p = 3.0 ×
10-5) was observed with visual stimulation (Fig. 4 – 5 and Table 4 – 1, n = 6 mice). Similar to the
ADC measurements, the reduction in ADC|| in the presence of visual stimulus was reversible
and no changes were detectable in the contralateral optic nerve with visual stimulation. A
decreased ADC|| was observed in all ipsilateral optic nerves with visual stimulation, with the
percent change varying between 7.3% and 13.6% across the members of this cohort. Again,
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ADC in the basal forebrain region was very stable across and within animals studied in this
group.
Using the ADCǁ and ADC results in Table 1 and assuming cylindrical geometry, the
fractional anisotropy for mouse optic nerve can be estimated [19]. For the resting state mouse
optic nerve FA = 0.90. With the applied flashing-light stimulus FA increases to 0.93. Via a
similar analysis, an orientationally-averaged diffusivity, D, of 0.71 m2/ms is estimated for the
resting-state optic nerve, which decreases by ~ 14 % to 0.61 m2/ms during the application of
visual stimulus.
Hypercapnia, by itself, produced no measureable changes in the optic nerve ADC (Fig. 4
– 6 and Table 4 – 2, n = 5 mice). An activation-induced reversible 25% decrease in optic nerve
ADC (p = 0.024) was observed in hypercapnic mice, essentially the same extent as seen in
room-air-breathing animals. This strongly suggests that the observed decrease in optic nerve
ADC with visual stimulation does not arise from a vascular effect [6] and is produced entirely as
a result of repeated axonal firing. The effect of hypercapnia and hypercapnia + stimulation on
ADCǁ was not investigated.
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Figure 4 – 4 Application of visual stimulus produces a significant drop in ADC for the optic
nerve of the stimulated eye [Baseline: 0.153  0.007 m2/ms (mean  sem), Stimulus On: 0.110
 0.006 m2/ms, ++: p = 0.0019], but no change for the contralateral, unstimulated eye. ADC
in the ipsilateral optic nerves returns to baseline values once again with removal of the stimulus.
Quantities shown are the mean  sem for image voxels within the optic nerve ROI in a group of
five experimental mice breathing room air. The insets depicts the measurements for the
experimental/ipsilateral and control/contralateral optic nerves in individual animals.
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Figure 4 – 5 Stimulus and ADC|| in optic nerve of mice breathing room air. Quantities plotted
are (mean ± sem). Stimulation produces no statistically-significant changes in ADC||
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Table 4 – 1
Measured ADC (mean  sem, n = 5) and ADC|| (mean  sem, n = 6) for In Vivo Mouse Optic
Nerve in Room-Air-Breathing Mice.
Condition

Baseline
Stimulus On
Stimulus Off

Ipsilateral

Contralateral

Ipsilateral

ADC

ADC

ADCǁ

2

(m /ms)

2

(m /ms)

(m2/ms)

0.176  0.019

0.168  0.018c

1.70  0.02

1.69  0.04

a

d

f

1.69  0.05

g

1.63  0.04

0.129  0.013
0.166  0.025

b

0.162  0.021

e

0.169  0.022

a: p = 0.0008 vs. Ipsilateral “Baseline” group
b: p = 0.005 vs. Ipsilateral “Stimulus On” group
c: p = 0.004 vs. Ipsilateral “Stimulus On” group
d: p = 0.01 vs. Ipsilateral “Stimulus On” group
e: p = 0.003 vs. Ipsilateral “Stimulus On” group
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Contralateral
ADCǁ
(m2/ms)

1.73  0.03
1.69  0.03

Figure 4 – 6 The effects of hypercapnia on measured ADC (mean ± sem) with and without
stimulation were investigated in a set of mice in order to quantify vascular contributions to the
observed phenomenon. The effects of stimulation on ADC (a 19% decrease) were similar to
changes seen in animals breathing room air.
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Table 4 – 2
Measured ADC (mean  sem) for In Vivo Mouse Optic Nerve in Mice Breathing Air or 5%
CO2/95% O2 (n = 5).
Condition

Ipsilateral

Contralateral

ADC

ADC

2

(m /ms)

(m2/ms)

Air, Baseline

0.184  0.022

0.200  0.016d

5% CO2, Baseline

0.192  0.020

0.198  0.007e

5% CO2 + Stimulus

0.155  0.017a,b

0.192  0.011f

Air, Stimulus Off

0.183  0.025c

0.202  0.019g

a: p = 0.03 vs. Ipsilateral “Air, Baseline” group
b: p = 0.008 vs. Ipsilateral “5% CO2, Baseline” group
c: p = 0.04 vs. Ipsilateral “5% CO2 + Stimulus” group
d: p = 0.002 vs. Ipsilateral “5% CO2 + Stimulus” group
e: p = 0.002 vs. Ipsilateral “5% CO2 + Stimulus” group
f: p = 0.007 vs. Ipsilateral “5% CO2 + Stimulus” group
g: p = 0.001 vs. Ipsilateral “5% CO2 + Stimulus” group
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4.4 Discussion
Our results show that in vivo diffusion MRI is capable of detecting the ADC decrease
(~28%) accompanying mouse optic nerve activation in medetomidine-anesthetized mice. The
activation-associated ADC decrease is independent of blood flow effects since hypercapnia
alone does not produce observable changes, and a similar activation-induced decrement in ADC
was seen in hypercapnic and air-breathing mice. The extent of in vivo ADC change is
comparable to that reported (31  8% decrease) for depolarization and osmotic swelling of ex
vivo rat optic nerve at 21ºC [20] supporting the notion that decreased ECS (Sen and Basser, 2005)
may be responsible for the detected ADC change.
Decreased ADC is a hallmark of repeated, synchronous neuronal discharge in CNS. For
example, 11 – 35% decreases in ADC were observed in 10 patients with complex partial status
epilepticus [21]. Application of trains of electrical shocks, administered via carbon electrodes
placed on the surface the rat brain, have been shown to result in an 8% decrease in gray-matter
water ADC [22]. Spreading depression also produces a transient ADC drop [23, 24]. While all
of these conditions produce membrane depolarization and subsequent cellular swelling [24], it is
likely the cellular swelling aspect that is directly responsible for the observed changes in tissue
water diffusion. For instance, membrane depolarization without cell swelling was not sufficient
to produce changes in ADC in ex vivo rat optic nerve [20].
In the current study, repetitive axonal firing within the optic nerve is expected to result
from the flashing light stimulus. The frequency of 1.4 Hz for the repetitive light flashing was
chosen since it is in the region of maximal response in the electroretinogram and visual evoked
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potential (voltage amplitude vs. flashing-stimulus frequency), as reported previously for
measurements in C57BL/6 mice [17].
In the visual system, light intensity information is encoded by the excitation frequency of
retinal ganglion cells [25] with faithful transmission of the photoreceptor action potentials to the
brain via the optic nerve. It is likely that during the 200ms-long pulses of bright light (repeated
at 1.4 Hz temporal frequency), the mouse optic nerves are repetitively transmitting action
potentials at frequencies of many tens of Hz [26, 27]. Ex vivo rat optic nerves have been shown
to undergo an ECS shrinkage that is more pronounced at higher rates of repeated electrical
stimulation [7]. While it was not investigated here, we would expect that the ADC response in
optic nerve should be graded in proportion to intensity of the applied stimulus. Earlier attempts
to measure changes in ADC|| and ADC in electrically-stimulated white matter of the ex vivo frog
spinal cord were unsuccessful [28], possibly due to the low-frequency (2.7 Hz average) of the
applied electrical stimulus.
Taken together, our results for ADC and ADCǁ predict an enhanced relative anisotropy
for activated white-matter fibers. Provided that stimulus paradigms can be devised for activating
specific white-matter pathways [3], it may be possible to monitor brain white-matter activation.
A recent report was aimed at detecting white-matter diffusion anisotropy changes in humans
with visual and tactile stimuli [29]. The conclusion reached in that study was that a large number
of measurements would be required for reliable detection of diffusion MRI signal changes. This
lack of sensitivity may reflect more on the need for higher spatial resolution (to avoid partial
volume effects) than a lack of robust physiological response.
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In the current study, we have used two diffusion-weighted measurements to estimate the
ADC of optic nerve with and without visual stimulation, assuming diffusion-attenuated signal
decays as a single exponential. As can readily be seen from Figure 3, this is approximately
correct over the range of b values employed for estimation of ADC and ADC||. Measurement
with diffusion-weighting perpendicular to the optic nerve and b = 1.40 ms/m2 result in a
relative signal intensity change of ~ 5.7% with vs. without stimulation.
Hypercapnia, a potent vasodilator and modulator of CNS blood flow (Rostrup et al.,
2000), by itself did not elicit signal changes in the mouse optic nerve. A modulation in tissue
ADC is one conceivable consequence of vasodilation (increased delivery of oxygenated blood)
with the same level of tissue oxygen consumption. The vascular network, especially the venous
network, contains some amount of relatively paramagnetic deoxyhemoglobin. The confinement
of this paramagnetic material to the venous network produces unintended tissue-internal
magnetic field gradients (in addition to the intentionally-applied diffusion-weighting gradients).
Reducing the tissue-internal field gradients, by reducing vascular deoxyhemoglobin content, can
produce an increased tissue ADC [30, 31]. No such effects were observable in hypercapnic mice
and essentially the same relative decrease in ADC was seen with stimulation in hypercapnic and
room-air-breathing animals.
We believe that ECS shrinkage in the optic nerve with visual stimulation is the cause of
the observed ADC decrease. Interestingly, for both the rat optic nerve [7] and rat spinal cord
gray matter [10], the extent of activity-dependent ECS shrinkage (from repeated electrical
stimulation) is correlated with age of the animal. Both sets of authors noted that a key
developmental feature in the maturation of these tissues is gliogenesis. Glial cells are often
implicated as the dominant contributors to activity-induced ECS shrinkage in neural tissue [32, 9,
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8]. As recently reviewed by Rash [11] the pan glial syncytium (involving gap-junctioninterconnected astrocytes, epindymocytes and oligodendrocytes--including direct involvement of
myelin-bounded cytoplasmic spaces), is believed to provide a dynamic mechanism for potassium
siphoning. This means of moving K+ and osmotically accompanying water away from the
axonal exterior is believed to allow for re-establishment of axonal membrane polarization
required for the repeated propagation of action potentials.
It should be noted, that in addition to glial swelling, there is evidence for activitydependent swelling of neuronal processes. Long-lasting swelling of dendritic spines has been
reported following a 30-second period of in vivo electrical stimulation in mouse brain [33]. Also,
transient axonal swelling, coincident with passage of the compound action potential has been
observed in the non-myelinated garfish olfactory nerve ex vivo [34]. Thus neuronal cells may
make some additional contribution to activity-dependent shrinkage of the extracellular space in
white matter. Regardless of the precise cellular origins, ECS shrinkage would be expected to
result in an overall reduction in tissue water diffusivity. Indeed, in mathematical modeling of
diffusion in white matter, the extracellular volume fraction is shown to be a dominant factor in
determining the overall tissue diffusion characteristics [35].
Regardless of any role that myelin itself might play in ECS shrinkage, which we believe
to be at the root of the stimulus-induced ADC changes in the optic nerve, intact myelin is a
requirement for normal white-matter functionality [36]. This suggests that functional diffusion
MRI measurements in white matter tracts could find utility as a specific marker of white-matter
lesions in demyelinating diseases (e.g., multiple sclerosis) with possible utility in directly
monitoring disease progression or treatment response.
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Chapter 5
Diffusion fMRI detects white-matter dysfunction in mice with acute optic
neuritis
This chapter represents the latest version of a manuscript that is targeted for submission to
NeuroImage.
(Tsen-Hsuan Lin, William M. Spees, Kathryn Trinkaus, Chia-Wen Chiang, Anne H. Cross, and
Sheng-Kwei Song)

Abstract
Optic neuritis is a frequent first sign of multiple sclerosis (MS). Conventional magnetic
resonance (MR) techniques provide a means to assess multiple MS-related pathologies, including
axonal injury, demyelination, and inflammation. However, a method to directly and noninvasively probe white-matter function could further elucidate the interplay of pathology and
dysfunction. Previously, we demonstrated a significant 27% activation-associated decrease in
the apparent diffusion coefficient of water perpendicular to the axonal fibers (ADC) in normal
C57BL/6 mouse optic nerve with visual stimulation using diffusion fMRI. Here we extend this
approach to explore the relationship between visual acuity, pathology, and diffusion fMRI in the
experimental autoimmune encephalomyelitis (EAE) mouse model of optic neuritis. Visual
stimulation produced a significant 25% decreased in ADC in EAE sham optic nerves, while
only a 7% ADC decrease was seen in acute-stage EAE mice. The reduced ADC response was
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consistent with impaired visual function in EAE eyes. Immunohistochemistry (IHC) data
confirmed pathologies of EAE optic nerves including axonal injury, demyelination, and
inflammation. These pathologies contributed impaired visual function and presumably produce
the resulting reduced activation-associated ADC response. Diffusion fMRI holds promise for
directly gauging in vivo white-matter dysfunction.
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5.1 INTRODUCTION
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease that mainly
affects the central nerve system (CNS), such as brain, optic nerve, and spinal cord [1-3]. Optic
neuritis is an inflammatory disorder of optic nerve and a frequent first sign of MS, which
produces blurred vision and/or pain in the affected eye due to inflammation and demyelination at
foci within optic nerve. The ten- and fifteen-year risk of developing clinically MS following a
single episode of optic neuritis was 38% and 50%, respectively [4, 5]. Hence, investigating and
treatment of optic neuritis might be crucial to reduce later development of MS and long-term
disability due to the significant relationship between MS and optic neuritis [6]. Therefore,
investigating functional deficits of optic neuritis may prevent or improve MS. Experimental
autoimmune encephalomyelitis (EAE), which is induced by inoculation with myelin
oligodendrocyte glycoprotein (MOG) peptide, is an animal model of human MS. Many
pathological features in EAE models parallel those characteristic of MS, including demyelinating
autoantibody response, axonal injury and loss, infiltration of encephalitogenic T cells and
macrophages, activation of microglia, microphages and astrocytes [7-10].
Non-invasive MR measurement has been widely used to investigate or diagnose
pathologies in EAE animal models and MS patients [11, 10, 12, 13, 2]. For instance, the apparent
diffusion coefficient (ADC), axial and radial diffusivity, mean diffusivity (MD), and fractional
anisotropy (FA) derived from diffusion-weighted images (DWI) or diffusion-tensor images (DTI)
can be used to identify axonal injury, demyelination, inflammation, and axonal loss [14, 7, 1517]. T1- and T2- weighted hypointensities result from higher cellularity and T2-weighted
hyperintensities reflect vasogenic edema, demylination, and axonal loss. Also, T1-weighted
contrast-enhanced images using Gd-DTPA or Mn2+ are indicative of compromised blood-brain
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barrier (BBB) or inflammation in EAE models and MS, which results in vasogenic edema [1822]. More accurate and novel approaches have recently been introduced to distinguish coexisting
pathologies, including neuroinflammation, axonal injury or pathologieas in gray matter using
diffusion basis spectrum image (DBSI) or diffusion kurtosis image (DKI) [23-26].
In addition, functional deficits are highly associated with or prior to aforementioned
morphologies. MRI, also indeed, holds potential to reveal functional integrity. For instance,
blood oxygen level dependent (BOLD) fMRI has been applied to study brain plasticity and
cortical activation in MS patients [27-30] to reflect motor or visual functional deficits. Since
conventional BOLD fMRI relies on local modulation of tissue blood volume and blood flow,
secondary to neuronal activation and metabolic demand, it is an approach which is largely
limited to cortical and gray-matter regions [31, 32] and mainly reflects post-synapse potential in
cortical region [33, 34]. In addition to post-synapse potential, action potential, the visual signal
propagation in CNS, should be considered as well to understand and assess functional deficits
because optic neuritis is prominently affected in optic nerve tracts.
Recently, diffusion fMRI has been introduced and suggested as an alternative approach
to identify neuronal and axonal functional integrity directly [35-40] Especially for white matter
tracts, diffusion fMRI offers a promising means to assess axonal function, since our previous
report showed a significant 27% ADC decrease was observed during visual stimulation in
healthy mouse optic nerves. Activation-associated ADC decreases in optic nerves were
independent of any vascular contribution [36].
White-matter tracts are prominently affected in MS, leading to various level of
neurological disability. It is estimated that ~ 66% of MS patients will experience an episode of
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optic neuritis at some point during the course of the disease (National MS Society,
www.nationalmssociety.org). A direct and non-invasive assessment of axonal function in optic
nerves would be crucial in understanding the MS pathophysiology and evaluating therapeutic
outcomes. In this study, diffusion fMRI was performed to investigate in vivo axon-function
deficits in EAE optic nerves.

5.2 Materials and Methods
All experimental procedures involving animals were approved by Washington
University’s Animal Studies Committee and conformed to the NIH Policy on Responsibility for
Care and Use of Animals.
5.2.1 Experimental autoimmune encephalomyelitis (EAE) mouse model
Fourteen 7-week-old, female C57BL/6 mice were obtained from Jackson Laboratory (Bar
Harbor, ME). Before immunization, mice were housed with 12-hour dark/light cycle for a week.
Mice were randomly separated into two groups: seven in the EAE group and seven in the sham
group. The mice in the EAE group were immunized with 50 µg MOG35-55 peptide emulsified
(1:1) in incomplete Freund’s adjuvant (IFA) and Mycobacterium tuberculosis. Pertussis toxin
(300 ng; PTX, List Laboratories, Campbell, CA) was injected intravenously on the day of
MOG35-55 immunization and two days later. The mice in the control group underwent the same
procedure with only IFA without MOG35-55 immunization.
5.2.2 Visual Acuity (VA)
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Mouse visual acuity was assessed using the Virtual Optometry System (Optomotry,
Cerebral Mechanics, Inc., Canada). Briefly, the virtual rotating columns were projected on the
LCD monitors with different spatial frequencies in cycles/degree (c/d). The mouse head
movement in response to the virtual column rotations was noted. The spatial frequency was
changed starting from 0.1 c/d with step size of 0.05 c/d until the mouse stopped responding. The
VA was defined as the highest spatial frequency the mouse was able to respond to the virtual
rotating columns. Prior to assignment of mice to EAE or experimental groups, all animals were
checked to ensure that their visual acuity was within the accepted normal range, 0.37 ± 0.02
cycles/degree (mean ± S.D.), which was similar to our previous report, 0.38 ± 0.003 c/d [23].
After immunization, VA was assessed daily in all mice. For animals in the EAE group, VA ≤
0.25 c/d (typically 8 – 13 days post-immunization) was defined as the onset of acute optic
neuritis [23]. For EAE animals, diffusion fMRI measurements were performed on the first day
at which their visual acuity was observed to be below 0.25 c/d. The mice in sham group did not
develop visual impairment, but underwent the diffusion fMRI procedure within the same time
range (8 – 13 days post-immunization)
5.2.3 Animal anesthesia and set-up
For initial setup mice were anesthetized with 1.5% isofluorane in O2. Anesthetized mice
were placed in a custom-made stereotactic head holder. The animal’s experimental eye remained
open and the contralateral eye was covered with parafilm and two layers of black electrical tape.
After careful setup the mouse and head holder were placed in the imaging cradle. Respiratory
rate and body temperature were monitored during experiments using an MR-compatible animalmonitoring system (SA Instrument, Inc., Stony Brook, NY). The body temperature was
maintained at 37 ± 0.5 ºC via a regulated circulating warm water pad underneath the mouse body
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and regulated warm air blown into the magnet bore. When mouse respiration was stable, a
subcutaneous 0.3 mg/kg bolus of medetomidine was administered followed immediately by a
continuous infusion of medetomidine at a rate of 0.6 mg/kghr through an in-dwelling
subcutaneous catheter. Isoflurane in the breathing-gas mixture was gradually discontinued
according to previously-described protocols until the animals were breathing room air [41].
5.2.4 Diffusion-weighted Image (DWI) protocol
MRI experiments were performed on a 4.7-T Agilent DirectDriveTM small-animal MRI
system (Agilent Technologies, Santa Clara, CA) equipped with a Magnex/Agilent HD imaging
gradient coil (Magnex/Agilent, Oxford, UK) capable of pulsed-gradient strengths of up to 58
G/cm and a gradient rise time ≤ 295 µs. An actively-decoupled 1.7-cm receive coil [42] was
placed on the top of the mouse head for MR signal reception. Then, the animal holder assembly,
including the receive coil was placed inside an 8-cm actively-decoupled volume transmit coil.
DWI measurements were carried out as previously described [36]. In brief, a multi-echo
spin-echo diffusion-weighted imaging sequence [43] was employed with following parameters:
TR = 1.5 s, TE = 37.1 ms, inter-echo delay = 23.6 ms, FOV = 20 × 20 mm2, matrix size = 256 ×
256 (zero-filled to 512 × 512), slice thickness = 1.3 mm. To get the final target image plane and
minimize partial volume effects, three middle-sagittal DWI images (diffusion gradient applied in
the slice-select direction) were acquired based on image planning derived from axial T2weighted images. The middle slice of the three sagittal DWI images clearly showed the
orientation of the pair of optic nerves, and the final image plane was adjusted carefully based
upon this middle sagittal DWI. The final targeted image slice plane was orthogonal to the optic
nerves to minimize partial volume effects. Two diffusion-sensitizing factors (b values), 0.1 and
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1.4 ms/µm2 (with δ = 5 ms and Δ = 18 ms), were applied to generate two DWIs (Fig. 5 – 1A and
5 – 1B). A train of three echoes were co-added to form the final MR images to increase
accumulated signal-to-noise ratio.
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Figure 5 – 1 Two diffusion-weighted images (DWI) with diffusion-sensitizing gradients applied
in the phase-encoding direction (left-to-right) with b values of 0.1 ms/µm2 (A) and 1.4 (B)
ms/µm2 were used to generate the resulting ADC map (C). The red box in panel B highlights
the location of optic nerves (bright) and surrounding cerebrospinal, which is highly
suppressed.ADC values in the optic nerves are considerably lower than that in other brain
tissues. The regular (nearly circular) shape of the optic nerves suggests good orthogonality
between the nerve axes and the slice plane, which minimizes partial volume effects.
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5.2.5 Visual stimulation
Visual stimulation was delivered by a flashing white LED (Cree, Model C503C-WAS)
placed 5 cm in front of mouse nose. A step-function signal of 1.4 Hz frequency with 200 ms
on/514 ms off and 4 V/0 V (on/off) was provided during stimulation. The detail of equipment
set-up was the same as that reported previously [36].
5.2.6 Diffusion fMRI strategy
For each mouse, three pairs of diffusion-weighted images were acquired. The first pair of
images without visual stimulation was taken as a baseline. Then, the stimulus-on DWI dataset
was acquired during application of flashing-light stimulation. Finally, the LED light was turned
off for the post-stimulus DWI acquisition.
5.2.7 DWI Data analysis
For measurements of diffusion perpendicular to the axonal fibers, signal decay with bvalue between 0.1 and 1.4 ms/µm2 is monexponential [36]. ADC maps were generated from the
pair of DWIs according to equation of Skejskal and Tanner [44] with code developed in-house
and written in MATLAB (Mathworks, Natick, MA). Optic nerve ROIs were drawn based on
operator-independent criteria as described previously [36].
5.2.8 Immunohistochemistry (IHC) staining in optic nerves
Following MR experiments, mice were perfused with 1 % phosphate-buffer saline (PBS)
followed by 4 % paraformaldehyde in 1 % PBS. The brain was excised and post-fixed in fixative
for 24 hours then transferred to 1 % PBS for storage at 4˚C until histological analysis. Mouse
optic nerves were embedded in 2 % agar blocks [45]. Then, the agar block was embedded in
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paraffin wax and 5-µm thick transverse slices were sectioned for IHC staining. Sections were
deparaffinized, rehydrated, and then blocked using 1 % bovine serum albumin (BSA, Sigma Inc.,
MO, US) and 5 % normal goat-serum solution for 20 minutes at room temperature to prevent
non-specific binding and to increase antibody permeability. Slides were incubated overnight at
4˚C with monoclonal anti-phosphorylated neurofilament antibody (SMI-31; 1:1000, Covance,
U.S.) to stain non-injured axons or rabbit anti-myelin basic protein (MBP) antibody (1:1000,
Sigma Inc., MO, U.S.) to stain myelin sheaths [46-48]. After rinsing, goat anti-mouse IgG or
goat anti-rabbit IgG conjugated Alexa 488 (1:800) were applied to visualize immunoreactivity of
phosphorylated neurofilament and MBP. Finally, slides were covered using Vectashield
Mounting Medium with 4’,6-diamidino-2-phenylindole (DAPI, Vector Laboratory, Inc.,
Burlingame, CA) to stain cell nuclei as well [48, 24]. Histological slides were examined with a
Nikon Eclipse 80i fluorescence microscope equipped with 60× water objective, and images were
captured with a black-and-white CCD camera with MetaMorph software (Universal Imageing
Corporation, Sunnyvale, CA) from the center of optic nerve. The 60× IHC staining images
(0.018 mm2) covered ~40% area of whole optic nerves (0.045 ± 0.013 mm2, mean ± S.D.).
Histological counts are reported for 7 EAE and 6 sham optic nerves in this study.
5.2.9 Histological data analysis
The whole field of SMI-31, MBP, and DAPI staining images at 60× magnification were
captured with the same fluorescence light intensity and exposure time. All captured images were
converted to 8- bit gray scale and analyzed using threshold, analyze particles and gray level
watershed segmentation functions in ImageJ (http://bigwww.epfl.ch/sage/soft/watershed/).
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Positive DAPI staining represented cell nuclei, and larger spots were shown in staining
images. DAPI-stained regions showed obvious contrast to the background, thus the quantified
number was directly calculated after applying the signal threshold.
5.2.10 Statistical analysis
The p-values of ADC change between first off (baseline) and stimulus on came from a
cluster linear repeated measures model, which took into account that there were three time points
for each eye and two eyes per mouse. The p-values of visual function (VA), SMI-31, MBP, and
DAPI were from nonparametric test for difference between sham and EAE groups and adjusted
using Wilcoxon Two-Sample Test. The correlation coefficients for VA with each of SMI-31,
MBP, DAPI, and decreased ADC were analyzed by Spearman’s rank correlation coefficient.

5.3 Results
5.3.1 Impairment of visual function and reduced activation-associated ADC response in EAE
optic nerves
Visual acuity (VA) of EAE and sham animals was assessed daily. Our previous report
mentioned that normal VA of C57BL/6 mouse was 0.38 ± 0.03 c/d (mean ± S.D., n=30). The
operational definition of onset acute optic neuritis was VA ≤ 0.25 c/d [23]. Before immunization,
normal VA was confirmed for each eye (n = 28, VA = 0.37 ± 0.02 c/d) to exclude mice with
poor vision due to uncontrollable factors. For the EAE mice in this study, the first time point at
which VA ≤ 0.25 c/d was observed, the operational definition of onset acute optic neuritis in this
animal model,was between day 8 – 13 post-immunization. Affected mice developed unilateral
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visual impairment. Group-averaged visual acuities of the EAE, sham and blocked eyes (n= 7, 7,
and 14, respectively) were 0.15 ± 0.08, 0.36 ± 0.02, and 0.36 ± 0.03 c/d (mean ± S.D., Fig. 5 –
2A). VA of EAE eyes showed a significant 58% (p < 0.005, EAE vs. sham) decrease at the
acute-stage time point when diffusion fMRI was performed.
ADC maps were generated from the diffusion-weighted image data (Fig. 1). The groupaveraged baseline optic-nerve ADC of affected acute-stage EAE optic neuritis eyes was higher
than in sham eyes (Fig. 5 – 2B and 5 – 2C, Table 5 – 1) Compared to their own baseline ADC
measurements, EAE and sham eyes showed a slight 7% (p = 0.45) and significant 25% (p <
0.005) ADC decrease during visual stimulus, respectively. No ADC changes were observed
between baseline and visual stimulus in the contralateral blocked eyes of EAE (p = 0.91) and
sham (p = 0.97) mice (Fig. 5 – 2B and 5 – 2C, Table 5 – 1) during applied visual stimulation.
These results imply that the activation-associated ADC decreases in EAE and sham optic nerves
are elicited by axonal activation. The EAE eyes exhibited impaired visual acuity and
correspondingly reduced ADC response with visual stimulation.
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Figure 5 – 2 In this mouse model of EAE optic neuritis, visual deficits typically developed in
only one eye. (A) Group-averaged visual acuity was significantly decreased by 58% (p < 0.005,
vs. sham, mean ± S.D.) in affected EAE eyes (n=7) compared with the normal vision of sham
eyes (n=7). Error bars indicate standard deviation. Also shown in A is the visual acuity of
contralateral blocked (n=14) eyes, which were used as a diffusion fMRI internal control for each
animal. (B) Group ADC maps were generated by averaging stacked ADC maps from EAE
(n=7) and sham (n=7) optic nerves, respectively (B). The baseline ADC of EAE optic nerves
(panel B and C) was higher than sham group due to demyelinated vasogenic edema in acute
stage (cf. Figure 3). Activation-associated ADC decrease was observed in both EAE and sham
optic nerves (B and C). (C) When compared to its own baseline, ADC significantly decreased
in sham optic nerves (25%, p < 0.005, B, C, and Table 1) with visual stimulation. In contrast,
only a slight ADC decrease was observed in EAE optic nerves (7%, p = 0.45, B, C and, Table
1). The optic nerves of blocked eyes showed no ADC change with visual stimulation (C and
Table 1), suggesting that the decreased ADC in stimulated EAE and sham optic nerves was
caused by axonal activity.
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Table 5 – 1
Group averaged ADC┴ of baseline, stimulus on, and stimulus off of EAE
(n=7), sham (n=7), blocked EAE and sham (n=14) eyes
EAE
Sham
Blocked

Baseline

Stimulus on

Stimulus off

0.200 ± 0.012

0.186 ± 0.015

0.207 ± 0.012

0.171 ± 0.014
0.188 ± 0.006

0.128 ± 0.008
0.189 ± 0.007

0.164 ± 0.016
0.196 ± 0.007

ADC┴ (µm2/ms): mean ± standard error of the mean
Blocked: contralateral EAE and sham eyes
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5.3.2 Axonal impairment was assessed by immunohistochemistry (IHC) staining
Previously, immunohistochemical (IHC) staining of phosphorylated neurofilament (SMI31, intact axon), myelin basic protein (MBP, myelin sheath), and 4’,6- diamidino-2-phenylindole
(DAPI, cell nuclei) have been shown to reflect white-matter integrity [46, 7, 24]. Representative
zoom-in 60× images (56% of 60× image) from EAE (n=7) optic nerves demonstrated obviously
axonal beading, low density of intact axons, less/thin myelin area, and higher cell nuclei density
(Fig.5 – 3A, 5 – 3D, and 5 – 3G) than sham optic nerves (n = 6, one optic nerve specimen was
damaged during tissue processing). Group-averaged counts of SMI-31, MBP, and DAPI (Fig. 5 –
3C, 5 – 3F, 5 – 3I and Table 5 – 2) in EAE optic neuritis onset showed a significant 22% [p <
0.005, 5.3 (± 0.6) × 105] decrease in density of intact axons and 17% [p < 0.005, 36.2 (± 2.5)]
myelin sheath area decrease compared with sham group [6.8 (± 0.5) × 105 and 43.6 (± 2.),
respectively] . Furthermore, the density of cell nuclei in EAE optic neuritis onset was increased
by 38% [p < 0.05, 5.8 (± 1.2) × 103] compared with sham group [4.2 (± 0.5) × 103]. Based on
IHC histological results, EAE optic nerves exhibited clear signs of axonal injury, demyelination,
and inflammation.
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Figure 5 – 3 Representative 60× immunohistochemistry staining images of phosphorylated
neurofilament (SMI-31, intact axon), myelin basic protein (MBP, myelin sheath), and 4’, 6dianidino-2-phenylindole (DAPI, nuclei) from EAE (A, D, and G,) and sham (B, E, and H) optic
nerves. EAE optic nerves demonstrated obvious axonal beading, lower axonaldensity (A),
reduced myelin area (D), and more cell nuclei (G). Group average IHC counts of EAE (n=7) and
sham (n=6) optic nerves (Table 2) reveal significant SMI-31 (C) and MBP (F) decrease and
significant DAPI (I) increase in the EAE group. IHC results suggest that axonal impairment,
demyelination, and inflammatory infiltration all contribute to visual deficits in acute optic
neuritis in this EAE mouse model.
Scale Bar: 25 µm
* indicates p < 0.005
** indicates p< 0.05
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Table 5 – 2
Quantitative immunohistochemistry results of EAE (n=7) and sham (n=6)
optic nerves
SMI31
(#/mm2)

MBP
(area %)

DAPI
(#/mm2)

EAE (n=7)

532897 ± 58103

36.15 ± 2.50

5819 ± 1160

Sham (n=6)

684574 ± 46864

43.60 ± 2.11

4225 ± 545

Counts: mean ± standard deviation
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5.3.3 Pathological trend and activation-associated ADC reduction
Visual function (measured by VA) highly correlated with intact axon density (Fig. 5 – 4A,
r = 0.77, p = 0.0012), myelin sheath area (Fig. 5 – 4B, r = 0.92, p < 0.0001), and cell nucleus
density (Fig. 5 – 4C, r = -0.73, p = 0.0029) assessed by positive SMI-31, MBP, and DAPI stains.
Our data suggested that impairment of optic nerve function resulting from axonal injury,
demyelination, and inflammation contributed to decreased VA at the acute stage. The reduction
of activation-associated ADC decrease was consistent and correlated well with impaired visual
function (Fig. 5 – 4D, r = 0.76, p = 0.0015) and suggested that diffusion fMRI provides a means
to non-invasively assess axonal-activation and axonal dysfunction resulting from pathological
changes in onset optic neuritis in this EAE mouse model.
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Figure 5 – 4 Pathological changes accompanying decreased visual acuity included reduced SMI31 counts (A, intact axon) and MBP (B, myelin area) and increased DAPI counts (C, cell nuclei).
The reduced activation-associated ADC change (decrease in ADC with stimulation expressed
as a percentage of baseline ADC) accompanied lower visual acuity (D). This data suggests that
axonal impairment and dysfunction can be assessed by diffusion fMRI.
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5.4 Discussion
This is the first study applying diffusion fMRI to assess functional deficits of a whitematter tract in vivo. The results presented here demonstrate a slightly attenuated, 7%, neuronalactivation-associated ADC decrease in EAE mice with onset optic neuritis compared to a
significant, 25%, decrease in sham mice. The results for EAE sham mice are comparable to our
previously-reported ~27% ADC decrease in normal mouse optic nerves [36]. The attenuated
activation-associated ADC response in the current study is consistent with impaired visual
function resulting from optic-nerve pathologies including axonal injury, demyelination, and
inflammation.
Visual signal conduction through the optic nerve depends on repeated cycles of
membrane depolarization/action potential/repolarization, which are accompanied by ion gradient
changes [49].Unlike BOLD fMRI is largely limited to gray matter for post-synaptic potential [33,
34], diffusion fMRI reveals the effect of action potential propagation in white matter. Diffusion
MRI would be expected to be sensitive extracellular space (ECS) shrinkage caused by transient
ionic gradient changes, osmotic shifts of water across cell membranes, or glial cell swelling
associated with changes in size and shape during axonal activation [50-56, 39, 57, 58]. In our
previous study, the observed activation-associated 27% ADC decrease was shown to be
independent of a vascular-coupling contribution [36]. Diffusion fMRI has the potential to
directly probe functional integrity in CNS axons without confounding blood-flow effects.
In this study, we measured VA by optokinetic response (OKR) for EAE and sham eyes to
reflect visual function, since VA with different spatial frequency in C57BL/6 mice reflected the
retinal efferent pathway to subcortical visual structures [59, 60]. Because psychophysical
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measurement, i.e. OKR, is taken 70% correct level compared to electrophysiological
measurement, i.e. VEP [61], VA by OKR measurement, therefore, reflects appropriately
electrical signal propagation in mouse visual system. The VA of EAE eyes in this sample was
significantly lower than in sham eyes (a 58% decrease, p < 0.005, Fig. 5 – 2A). The histological
results showed that the EAE mice in this sample developed inflammation, demyelination, and
axonal injury (Fig. 5 – 3C, 5 – 3F, and 5 – 3I), suggesting the pathologies of optic neuritis in
EAE mice affected their visual function.
According to VEP measurement in mouse visual system, the optimal visual stimulation
condition was determined [61] and applied to this study. During diffusion measurement with
visual stimulation, decreased ADC and unchanged ADC were observed in unblocked and
blocked eyes of sham mice, respectively (Fig. 5 – 2B and 5 – 2C) suggesting the ADC directly
revealed electrical/action potential in optic nerve. For the unblocked eyes, the ADC change in
EAE optic nerves was less than sham mice and revealed that the dysfunction of axonal activity.
The results corresponded to lower VA and pathologies. The baseline of ADC in EAE optic
nerves may result from acutely demyelination or vasogenic edema since radial diffusivity or
ADC increase reflected those two pathologies have been reported in EAE mice or MS patients
[14, 7, 23, 19, 62, 63].
In CNS, compound action potential (CAP) propagation causes ion gradient change and
needs large amount of ATP to maintain ion homeostasis and neurotransmission including about
60-80% and 10-20% ATP consumption, respectively [64]. Mitochondria are the major source of
axonal ATP required to maintain CAP propagation by means of saltatory conduction [65]. At
acute stage of MS patients and EAE animal models, lymphocytes cross BBB and attack myelin

152

in CNS [3]. Lymphocyte-induced inflammation activates microglial cells and macrophages and
then induced more nitric oxide (NO), which also blocks saltatory conduction propagation and
reduces mitochondrial function in CNS of MS patients and EAE animals [66-68]. Demyelination,
which also leads to impaired saltatory conduction [69, 70], has been shown to result in,
redistribution of and/or increases in voltage-gated Na+ channel density in the membrane of
demyelinated axons in order to maintain nerve conduction, and it leads to increased energy
demands due to altered channel expression and demyelination [71, 70, 72]. Therefore, inhibition
of mitochondrial due to NO production and increase of energy demand due to Na+-channel
redistribution might result in ion dyshomeostasis and energetic imbalance. Declining energetic
status results in reduced Na+/K+ ATPase pump activity and, hence, increases intracellular Na+
concentration. In such situations, Ca2+ influx via action of the Na+/Ca2+ exchanger has been
postulated to produce mitochondrial dysfunction, axonal damage, and ultimately necrosis [73, 74,
66, 71, 75]. Other mechanism such as the excessive glutamate production by inflammatory cells
leads to glutamate-induced Ca2+ overload and inhibition of mitochondria, and it finally results in
excitotoxicity of axons [76, 75, 77, 71]. Therefore, we speculate that the inflammation,
demyelination, ion-dyshomeoastasis, and energetic imbalance in CNS of MS patients or EAE
animals affect functional integrity and could be an early event.
Our histological results demonstrated that EAE optic nerves in this sample developed
axonal injury, demyelination, and inflammation (Fig. 5 – 3); the pathologies were consistent with
impaired visual function as well (Fig. 5 – 4A ~ 5 – 4C). The results were in agreement with
aforementioned impaired visual signal propagation in MS patients or EAE animals. The change
of decreased activation-associated ADC response was consistent with impaired visual acuity
(Fig. 5 – 4D). Therefore, this non-invasive in vivo functional measurement may offer a new
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approach to directly reflect the axonal activity. Contributions from retinal dysfunction at the
early time point measured herein are unlikely as previously retinal ganglion cell (RGC)
pathological changes have been shown to occur later in the progression of optic neuritis [78, 79].
This is also consistent with our own RGC histological data (Chiang et al., unpublished).
Optic neuritis is frequently the first sign of MS in patients [4]. Inflammation and
demyelination of the affected optic nerves produces impaired visual function (blurred vision or
occasionally total blindness). In EAE animal models of MS, several groups demonstrated visual
dysfunction accompanying optic neuritis via behavioral or visual evoke potential (VEP)
measurements [80, 81, 8, 82]. These measurements rely upon functionality of the entire visual
pathway including retina, optic nerve, visual cortex, and/or conscious response of the brain.
Thus they may lack specificity in terms of demonstrating the location and contribution of
specific lesion sites. Because ADC of diffusion fMRI is a direct measurement of white-matter
function, hence, we speculate that activation-associated ADC decrease, which likely result from
ECS shrinkage during axonal activation, in EAE optic nerves is less than sham mice during
visual stimulation. Decreased ADC change was observed in EAE optic nerves since they bear
dysregulation of ion gradients and ion dyshomeostasis owing to mitochondrial failure and
demyelination. That is, the EAE optic nerves with prolonged or impeded CAP propagation lose
the abilities to modulate transient ion gradient change and osmotic shift of water across cell
membranes.
To conclude, the attenuated activation-associated ADC response at the onset of optic neuritis in
this animal model likely reflects in vivo functional deficits at the optic-nerve axonal level. The
impaired EAE optic nerves demonstrated an attenuated response compared to sham optic nerves
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during application of the same stimulation protocol. The functional pathologies in EAE optic
nerves using diffusion fMRI provide a unique perspective on the consequences of inflammatory
demyelinating pathologies. In vivo diffusion fMRI is a promising tool for investigations of
pathological mechanisms, therapeutic targets, and/or longitudinal assessment in white-matter
tracts.
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Chapter 6
Conclusion
Optic neuritis is frequently the first sign of multiple sclerosis (MS). The pathologies
result from lymphocytes crossing blood-brain barrier (BBB) and then attacking myelin in central
nervous system (CNS) and, finally, lead to inflammation, demyelination, and axonal injury [1].
Better understanding of the mechanism and relationship of optic neuritis and MS will lead to
more efficient treatment strategies. Recently, MRI has been widely used as a non-invasive
approach to detect and diagnose the morphological changes of MS over several decades to track
or diagnose the disease process [2-5]. Functional deficits might be an early pathological event
that precedes the morphological changes. However, currently the most commonly used
functional test is BOLD (blood oxygen level dependent) fMRI, which mostly focuses on cortical
regions, but is limited in the analysis of white-matter function [6]. Magnetic resonance imaging
(MRI) can reflect different physical properties in tissues, such as T1, T2, and water diffusivity.
We further took advantage of these properties to dynamically investigate in vivo functional
activity in EAE mice, the mouse model of MS, which also develops optic neuritis.
6.1 Axonal transport using manganese-enhanced MRI (MEMRI)
Axonal transport, the transport of proteins and organelles within the axons, is crucial to
maintaining normal neuronal function. There are multiple reports in the literature that axonal
transport dysfunction or disruption is an early event of neurodegenerative disease, such as
Alzheimer’s disease [7]. However, few studies focus on the integrity of axonal transport in MS
patients or experimental autoimmune encephalomyelitis (EAE) animal models. Therefore,
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investigating axonal transport in the EAE mice might provide pathological information about MS
before morphological changes. Manganese-enhanced MRI (MEMRI) is a promising tool to tract
dynamic Mn2+ transport within visual system which will allow us to investigate axonal transport
in vivo. Since Mn2+ is paramagnetic, MEMRI provides obvious contrast on T1-weighted (T1W)
image and as a Ca2+ analogue it can enter neurons via voltage-gated Ca2+ channels and be
transported down the axon[8, 9]. However, the cellular toxicity of Mn2+ has long been
recognized as overexposure causes Parkinsonism [10]. Hence, it is important to determine the
Mn2+ dosage which maximizes MR detectability and minimizes toxicity. Therefore, before we
apply MEMRI to EAE mice, the optimized dosage for mouse visual system is needed.
In Chapter 2, we compared topical loading with intravitreal injection of MnCl2 for
MEMRI of mouse optic nerve to determine the optimal concentration and volume of MnCl 2 dose.
Visual functional was assessed longitudinally. In vivo MEMRI and diffusion tensor imaging
(DTI) of optic nerves as well as the T2-weighted (T2W) MRI of mouse retina were used to
assess the integrity of visual system tissue after MnCl2 loading. After MRI studies, postmortem
histology was performed to validate in vivo MRI findings. The results revealed that the
previously suggested safe dose for intravitreal injection of MnCl2 caused transient retinal
swelling and visual acuity impairment with full recovery within one day in mice. In contrast, the
literature reported dose for topical MnCl2 loading caused adverse degeneration of photoreceptors
and significantly impaired visual acuity in mice. We not only examined the toxicity of MnCl2
loading, but also demonstrated the utility of in vivo MRI contrast as a surrogate marker of visual
system tissue integrity.
In Chapter 3, we compared the axonal transport rate in EAE and sham mouse optic
nerves using MEMRI with an intravitreal injection of 0.25 μL of 0.2 M MnCl2: the optimal
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dosage that was determined in Chapter 2. In order to understand the mechanism of functional
deficits at the acute stage, we defined and determined the onset of optic neuritis by mouse visual
acuity using the Virtual Optometry System (Optomotry, Cerebral Mechanics, Inc., Canada).
MEMRI was performed in EAE eyes as soon as visual acuity dropped (~ 11.3 ± 1.9 days postimmunization). The mice in the sham group did not develop visual impairment but underwent
the same MEMRI procedure at the similar time range. During the MEMRI procedure, mice were
directly put in the scanner after intravitreal injection. A series of 3D-T1W images was acquired
every 0.55 hour from 0.55 – 5.5 hours post-injection. The quantitative data showed that
comparing to sham optic nerve, the accumulation rate in EAE mice with moderate and severe
optic neuritis was significantly decreased by 19% and 38%, respectively. Similarly, the transport
rate in EAE mice with moderate and severe optic neuritis was significantly decreased when
compared to sham optic nerve by 43% and 65%, respectively. Postmortem histology confirmed
the EAE mice with optic neuritis in this sample developed inflammation, demyelination, and
axonal injury pathologies. The degree of axonal transport deficits correlated well with impaired
visual function as well as histological pathologies. In conclusion, MEMRI holds potential to
track in vivo dynamical axonal transport.
6.2 Axonal Activity using diffusion fMRI
Another functional component of neuronal function in the visual system is the electric
transmission of the visual signal via depolarization of different ion channels in optic nerve
through brain [11]. Myelin plays a role to speed up and conserve signal delivery, so-called
saltatory conduction. Since MS is a demyelinative disease, the signal propagation should be
blocked or delayed. Currently, fMRI mainly depends on BOLD signal change to identify neuron
activity in gray matter indirectly through vascular changes. Several reports have explored
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functional deficits in gray matter of MS, such as motor and visual cortex [12-15]. However,
electrical signal propagation also largely relies on white matter, but there have been limited
studies focusing on it in MS. Since visual conduction leads to repeated cycles of membrane
depolarization, action potential, and repolarization, these successive effects are highly associated
with transient ionic gradient changes, osmotic shift of water across cell membranes, and sizeand shape-related glial cell swelling [16-25]. Finally, those effects might results in the
extracellular space (ECS) shrinkage. Displacement of water molecules in tissue can be detected
by diffusion MRI. Le Bihan et al. reported that during visual stimulation, increased signal
intensity (2%) was observed in diffusion weighted images [26]. That is, apparent diffusion
coefficient (ADC) was decreased and could be a direct means to reveal neuronal activity.
However, Miller et al. later reported that the vascular effects also led to ADC decrease without
visual stimulation [27]. Unlike gray matter, diffusion MRI might be a potential means to reveal
neuronal activity in white matter due to limited blood flow and blood volume. Hence, ADC
might be sensitive to stimulation-associated ECS shrinkage, which limits the displacement of
water molecules.
In Chapter 4, we gave mice visual stimulation and measured ADCand ADC|| using
standard diffusion measurement. A 27% stimulus-associated ADCdecrease, which is the ADC
perpendicular to optic nerve/axonal fibers, was observed. No change ADC||, which is the ADC
parallel to optic nerve/axonal fibers, was shown. The stimulus-associated ADCdecrease was
repeatable. To confirm that the ADCdecrease was independent of vascular contribution, we
performed the same experimental procedure in hypercapnia mice. The results showed that during
visual stimulation, a significant 20% ADC decrease was observed suggesting there were no
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vascular effects. Therefore, diffusion measurement in white matter could directly reveal axonal
activity.
In Chapter 5, we further applied the diffusion measurement with visual stimulation in
EAE mice with optic neuritis to assess functional integrity in optic nerves. After immunization,
daily visual acuity was confirmed by Virtual Optometry System (Optomotry, Cerebral
Mechanics, Inc., Canada). Diffusion fMRI was performed in EAE eyes as soon as visual acuity
dropped (~ 10.6 ± 1.7 days post-immunization). The mice in the sham group did not develop
visual impairment but underwent the same diffusion fMRI procedure at the similar time range.
The results showed that visual stimulation produced a significant 25% stimulus-associated ADC
decrease in sham mice, which is comparable of our previous report in normal mice (~27%). Only
a statistically insignificant 7% stimulus-associated ADC decreased was seen in acute-stage EAE
mice. The reduced ADC response was consistent with impaired visual function (lower visual
acuity) and histological pathologies including axonal inflammation, demyelination, and axonal
injury. The results also implied that diffusion fMRI holds promise for directly gauging in vivo
white-matter dysfunction.
6.3 Conclusion
To conclude, axonal transport disruption and axon-activity dysfunction, at optic neuritis
onset in EAE mice were confirmed by MEMRI and diffusion fMRI, respectively. These
functional deficits were highly correlated with impaired visual function and morphological
changes. Therefore, non-invasive MRI not only provides a way to reflect morphological changes
but also holds potential to assess functional integrity in white matter.
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Toxicity of Mn2+ in MEMRI with topical loading
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Introduction

(A)

(B)

(C)

(D)

Manganese enhanced MRI (MEMRI) has been widely applied to
investigate axonal transport in the rodent visual pathway. Intraocular
injection is an established approach for MnCl2 loading. Bearer et al. [1]
intraocular dose allowing detectable MEMRI effect. In a recent report,

Optic Nerve

Retina

have reported the impaired visual evoke potential (VEP) at the lowest

Lateral Geniculate
Nucleus

Superior
Colliculus

Fig. 1 Four representative axial images from 3D T1W data
set one day after 0.75 M MnCl2 loading. Visual pathway was
enhanced from (A) right retina, (B) right optic nerve, (C) left
lateral geniculate nucleus, and (D) left superor colliculus ; (E)
oblique T1W image that included retina and optic nerve
showed Mn2+ enhanced signal at right side.

(E)

the noninvasive topical MnCl2 loading [2] was demonstrated without
the need of invasive intraocular injection of MnCl2. However, the effect
of topical MnCl2 loading on visual function was not evaluated. In this
study, the toxicity of MnCl2 was evaluated by visual acuity (VA)
measurement [3,4] as well as optic nerve and retina MRI.

Material and Method
Four groups of female C57BL/6 mice at 8 weeks of age were examined: control
(n=4), 0.5 (n=4), 0.75 (n=6), and 1 M (n=5) of MnCl2 loading. Mice were
anesthetized using 1.5% isoflurane/oxygen for topical loading of 20µl of MnCl2 on
the right eye. An additional 20µl of MnCl2 was applied every 20 min to compensate
the volume loss due to evaporization. The body temperature was maintained at 37

n0.75M =6
n1M =5

ºC during loading with an electric heating pad. After an hour, a lint free tissue was
used to remove the solution. Twenty-four hours after loading, mice were
anesthetized and imaged on a 4.7 T animal scanner using a 3D gradient echo
sequence with the following parameters: TR 15ms TE 2.63ms, flip angle 20,
number of averages 16, FOV 15 × 15 mm2, and matrix size 128 × 128 × 64 (zerofilled to 256 × 256 × 64 ). Region of interest (ROI) included retina, optic nerve

Fig. 2 Visual acuity (VA) time course after 0.75 and 1 M MnCl2 loading on
right eyes. VA irreversibly decreased from normal (0.4) to complete blind
(0) after 1 M loading. VA decreased to 0.1 (not completely bind) and
recovered at day 5 after 0.75 M loading.

(A)

(ON), and superior colliculus (SC). Visual acuity (VA) was assessed daily from

(B)
(B)
(B)

(A) (A)

(B)
(B)

1 to 7 days. Optic nerve were imaged on 4.7 T animal scanners with multiple-echo spin-ehco
diffusion weighted sequence at days 1 and 7 with the following parameters: TR 1.5s, TE 34 ms,

(D)

inter-ehco delay 19 ms, FOV 22.5 × 22.5 mm2 , matrix size 192 × 192 (zero-filled to 384×384 ),

(E)

thickness 0.5 mm. Retina images were performed on an11.74 T scanner with a standard spin
echo sequence with the following parameters: TR 2s, TE 34ms FOV 12 × 12 mm2 matrix size

sclera

256 × 256 (zero-filled to 512 × 512).

sclera

Results & Discussion
At one day after 0.75 and 1 M MnCl2 loading on right eyes, significant T1W enhancement was
seen in the right retina, right optic nerve, left lateral geniculate nucleus and left superior colliculus

retina
layer

choroid

choroid
retina
layer

(Fig. 1). Only slight enhancement of retina was seen in mice loaded with 0.5M MnCl2. Significant
visual function impairment was seen in both 0.75 and 1 M MnCl2 loaded eyes (Fig. 2). Upon 1 M
MnCl2 loading, irreversible VA decreased from normal (VA = 0.4) to complete blindness (VA = 0)
from 1 day after loading. In 0.75 M MnCl2 loaded eyes, VA decreased to 0.1 (not completely
blind) at 1 day after and recovered to approximately the normal range at 5 days after loading (Fig.
2). There was no detected axonal or myelin injury in optic nerve loaded with 1M MnCl2 at 1 and
7 days after loading (Fig. 3). However, a significant reduction in retinal thickness (~27%
compared to the control) was seen in eyes loaded with 1M MnCl2 (Fig. 3).

Conclusion

Fig. 3 DTI parameters of optic nerve, indicated by the
arrow, in (A) RA, (B) radial, and (C) axial diffusivity maps
after 1 M MnCl2 loading at the right eye were not affected.
T2W images showed that the right retina (D) after 1 M
MnCl2 loading was thinner than the control retina (E).
Thickness decreased by 27 % after MnCl2 loading.

Our data suggested that although topical loading of 1 M MnCl2 did not injure optic nerve, as indicated by normal DTI parameters, the damaged retina was likely
responsible for the irreversible loss of vision. The reduced retinal thickness may reflect the loss of retinal cells. The success in optic nerve enhancement after loading
may suggest the retinal ganglion cells were not lost and still capable of uptake Mn2+. Alternately, the retinal ganglion cell was damaged after uptake of Mn2+ and
transporting to its axon. This is the first time retinal integrity was assessed after MnCl2 loading.
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Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis
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Introduction

Materials and Methods

Visual Acuity
(cycle/degree)

0.45
Conventional fMRI, based on blood-oxygen level dependent
0.3
(BOLD) signal change, to identify neuronal activation is largely
limited to assess gray matter activation. We have developed a
0.15
diffusion fMRI method to detect white matter functional activation
in normal, healthy mouse optic nerves and observed a 27%
0
decrease in the water apparent diffusion coefficient perpendicular
EAE
Healthy
Blocked
(Blind)
to the axonal fibers (ADC⊥) upon flashing light stimulation.
(Sham)
Meanwhile, we excluded the vascular contributions to the ADC⊥
Figure 1 Averaged visual acuity of EAE (n=7),
change via measurements in hypercapnic mice [1]. In the current
sham (n=7), and contralateral blocked (n=14)
study, we extend this method to non-invasively assess the
eyes (measured before MR experiments)
response of experimental autoimmune encephalomyelitis (EAE)
showed the poor vision of EAE eyes and normal
mouse optic nerves to visual stimulation with ongoing optic
vision of sham and blocked eyes. Note: EAE
neuritis. Our findings suggest that acute axonal pathologies
mice in this sample of animals developed
present at the onset of optic neuritis led to decreased axonal
unilateral visual impairment.
activation in EAE mice. Thus, diffusion fMRI holds the potential to
provide a non-invasive assessment of functional integrity of CNS axons.
On
Off
(A)
Baseline
Healthy
(Sham)
(n=7)

b = 0.1 ms /μm

2

b = 1.4 ms /μm

2

Figure 2 Two diffusion-weighted images
2
(DWIs) with 0.1 and 1.4 ms/μm b-values
were calculated to generate apparent
diffusion coefficient (ADC┴) map. Yellow box
indicates the location of optic nerves

(B) *P <0.005 compare to its own baseline
ADC﬩(µm2/ms)

0.25
Animal Model: EAE was induced in seven female ten-week-old C57BL/6 mice
0.2
with MOG35-55 peptide in complete Freund's adjuvant emulsion. The other
seven age-matched control mice (sham group) underwent the same
EAE
0.15
procedure without MOG35-55 immunization. For EAE mice, daily visual acuity
(n=7)
*
0.1
(VA) was measured and MR was performed when VA ≤ 0.25 cycle/degree
(Fig. 1). Typically, this occurs by 9-13 days post-immunization. Daily VA
EAE (n=7)
Blocked
0.05
Sham (n=7)
measurements assured normal visual function in control mice [2]. Diffusion(n=14)
Blocked (n=14)
weighted image (DWI) protocol: Experiments were performed on a 4.7-T
2
0
μm /ms
Agilent small-animal MR scanner with a multiple-echo spin-echo imaging
Baseline Stimulus onStimulus off
sequence [3] with the following parameters: TR = 1.5 s, TE = 37.1 ms, interFigure 3 Averaged ADC┴ maps of sham, EAE, and contralateral blocked eyes at
2
echo delay = 23.6 ms, FOV = 20 × 20 mm , matrix size = 256 × 256 (zerobaseline, with and without stimulation (A). Comparing to its own baseline map, sham
filled to 512 × 512), and thickness = 1.3 mm. The image slice was planned
group showed obvious ADC┴ decrease. Statistical ADC┴ average plot (B) was in
carefully to be orthogonal to the optic nerves, thus minimizing partial volume
effects. A pair of one-direction (perpendicular to optic nerve) DWI was
agreement with the pattern of averaged ADC┴ maps (A). A significant 25% ADC┴
2
acquired with b-value = 0.1 and 1.4 ms/μm , δ = 5 ms, and Δ = 18 ms.
decrease was observed in sham group. EAE group only showed a slightly 5%
Acquisition time was 12.8 minute for each pair of DWI images [1]. Visual
decrease. Regarding blocked eyes, there was no difference between the scans of
stimulation: A white LED light was placed 5 cm in front of mouse nose for
baseline and stimulation.
stimulation of the experimental eye. The other eye was covered with parafilm
and blocked using black electrical tape. Diffusion fMRI strategy: We acquired
one baseline DWI dataset without stimulation. Then, the stimulus-on DWI dataset was acquired
SMI31
MBP
SMI32
during application of flashing light stimulation. Finally, the LED was turned off for last DWI
acquisition [1]. Data analysis: ADC⊥ maps were generated from two DWIs (Fig. 2). ROI was
selected using the same determination as our previous study [1]. Histology: mice were perfusion
Sham
fixed immediately after the in vivo MRI for immunohistochemical staining.
(Healthy)

Results
Color-coded group-averaged ADC⊥ maps for the different experimental groups are shown in
Figure 3A. Group-averaged ADC⊥ at baseline, with and without visual stimulus for EAE, healthy,
and blocked optic nerves are depicted in Figure 3B. In healthy optic nerves, application of visual
stimulus led to a significant ADC⊥ decrease (~25%) while in EAE optic nerves only a slight ADC⊥
decrease (~5%) was observed. ADC changes were reversible with cessation of stimulus.
Blocked eyes showed no difference between baseline and stimulation scans. From Figure 3A it
can also be appreciated that optic nerves in EAE mice are slightly swollen. Representative
SMI31 (intact axons), MBP (myelin sheaths), and SMI32 (injured axons) staining images of optic
nerves were showed that EAE optic nerve developed axonal beading, distorted myelin sheaths,
and injured axons (Fig. 4).

Conclusion

EAE

Figure 4 Representative 60× SMI31 (intact axon), MBP (myelin
sheath), and SMI32 (injured axon) staining images from control and
EAE mouse. EAE mouse optic nerve showed obviously axon
beading (SMI31), distorted myelin sheath (MBP), and positive
SMI32 staining.

Our results demonstrate that diffusion fMRI can non-invasively differentiate between patterns of
in vivo axonal activation in healthy and diseased optic nerve. Histology of retinal samples is
ongoing, however, since measurements are made early in the EAE time course, it is likely that the pathology is localized to the optic nerve-- prior to any retinal ganglion cell
loss [4]. More broadly, with other stimulus paradigms, this technique may enable global detection of white-matter dysfunction throughout the CNS.
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Axonal transport rate decreased at the onset of optic neuritis in EAE mice
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Introduction

1

Multiple sclerosis (MS) is an inflammatory demyelinating disorder of central nervous system (CNS). Frequently, optic neuritis (ON) is an early symptom of MS . Axonal
2
transport deficits are an early event of many neurodegenerative diseases . However, few reports have assessed axonal transport rate in MS or in experimental autoimmune
2+
2+
encephalomyelitis (EAE). EAE induced in C57BL/6 mice is a widely used animal model of MS and exhibits many MS-like pathologies, including ON. Mn , a Ca analog, is
paramagnetic to shorten T1 relaxation time and crosses cell membrane trough voltage-dependent Ca2+ channels. Hence, in vivo manganese-enhanced MRI (MEMRI)
provides a way to investigate real-time axonal transport in rodent visual pathway. In this study, we measured visual acuity (VA) by optokinetic response (OKR) to define onset
3
of ON in EAE mice . Then, MnCl2 was injected in the vitreous of sham and EAE mouse eyes, followed by series of time-lapse T1-weighted (T1W) images to compare axonal
transport rate. The results suggested that axonal transport impairment was present and correlated with impaired visual functional and pathologies. The results of this study
showed that axonal transport deficit is an early event of functional deficit of optic nerve in EAE mice. In vivo MEMRI is ideal to investigate axonal transport.

Materials and Methods
Animal Model: EAE was induced in 10 female eight-week-old
C57BL/6 mice with MOG35-55 peptide in incomplete Freund's
adjuvant emulsion. The other six age-matched control mice (sham
group) underwent the same procedure without MOG35-55
immunization. Daily visual acuity (VA) was measured and MEMRI
was performed at VA ≤ 0.25 cycle/degree (c/d). According to
severity of ON, mice were separated into three groups, sham (VA
= 0.35/0.4 c/d), moderate (VA = 0.2/0.25 c/d), and severe (VA = 0
c/d) ON. Intravitreal injection: A dose of 50 nmol MnCl2 (0.25μL
of 0.2 M) was delivered to vitreous space at a rate of 3μL/min with
34-gaugue needle4. MEMRI: A pair of 8-cm diameter volume and
1.7-cm diameter surface active-decoupled coils was used.
Experiments were performed on a 4.7-T Agilent small-animal MR
scanner with a standard 3D gradient echo sequence with the
º
following parameters: TR = 15 ms, TE = 2.63 ms, flip angle = 20 ,
FOV = 15 × 15 × 22 mm3, matrix size = 128 × 128 × 64 (zero-filled
to 256 × 256 × 128), acquisition time = 32.8 minutes, number of
signal average = 16, and ten successive sets of 3D-T1W images
were captured at ~0.55 – 5.5 hours post-injection. B1inhomogeneity correction: 3D-T1W image of a 2% agar gel
phantom was placed underneath surface coil using the same
acquisition MEMRI parameters with 64 averages. The raw 3DT1W image of mouse brain was divided by the 3D-T1W image of
phantom voxel by voxel using ImageJ to correct B1inhomogeneity. Data analysis: The corrected 3D-T1W image set
was adjusted and rotated to oblique plane that covered retina and
optic nerves before chiasm (Fig. 1). Accumulation rate
calculation: ROIs (region of interest) were drawn on Mn2+-loading
optic nerves and reference area for all oblique corrected T1W
images (Fig. 2A). The slope of normalized intensity, calculated by
2+
ratio of Mn -loading ROI and reference area, was accumulation
rate (Fig. 2C and 2E). Transport rate calculation: ROI lines were
drawn on Mn2+-loading and contralateral optic nerves for all
2+
oblique corrected T1W images (Fig. 2B). Arrival of Mn was
determined by intensity of voxel ≥ threshold (mean + 2SD of
contralateral ROI line). The slope of normalized displacement
2+
(number of voxels with Mn arrival), normalized by the whole
optic-nerve ROI line, was transport rate. After converting with
image resolution, transport rate was converted to millimeter per
hour (Fig. 2 D and F). Histology: mice were perfusion fixed
immediately after the in vivo MEMRI for immunohistochemical
staining of the optic nerve.

Results

Figure 1 A serial time-lapse
oblique corrected T1W images
from representative mice from
sham, moderate-ON, and
severe-ON optic nerves were
presented to demonstrate the
2+
different degree of Mn enhancement from 1.1 – 5.5
hours post-injection.
Figure 2 For accumulation rate,
ROIs were drawn on Mn2+loading optic nerve and
reference muscle for each time
point (A). The slope of each
normal intensity tend was
accumulation rate (C). With VA
decreased, lower accumulation
rate was shown (E). For
transport rate, ROI lines were
2+
drawn on Mn -loading and
contralateral optic nerves (B).
The slope of each normalized
displacement trend was
transport rate in percentage
optic nerve/hour (D). After
converting with image
resolution, transport rate was
acquired in millimeter/hour (F).
When VA decreased, lower
transport rate was observed
Figure 3 Representative 60x TUJ1
(βIII-tubulin), SMI31 (intact axon),
MBP (myelin sheath), and DAPI
(cell nuclei) staining from sham,
moderate-ON, and severe-ON optic
nerves. EAE optic nerves showed
the sign of axonal transport deficits
(less microtubule-associated βIItubulin), axonal injury (less axon),
demyelination (less myelin area),
and inflammation (more cells).
Scale bar: 25μm

Compared to sham optic nerves, Mn2+ accumulation rate was
significantly decreased by 19% (p < 0.005, moderate EAe) and
38% (p < 0.005, severe EAE) (Fig. 2E). The accumulation rate
2+
was 23% (p < 0.05) slower in the EAE mice with severe ON than that with the moderate ON (Fig. 2E). Compared to sham optic nerves, Mn transport rate was significant
decreased by 43% (p < 0.05, moderate EAE) and 65% (p < 0.005, severe EAE). Representative TUJ1(microtubule-associated βIII-tubulin, staining the base structure for
5
kinesin motor protein movement) , SMI31 (intact axon), MBP (myelin sheath), and DAPI (cell nuclei) stains showed that EAE optic nerves developed axonal transport deficits,
axonal injury, demyelination, and inflammation.

Conclusion
Our results demonstrate that MEMRI can provide an in vivo real-time quantification of axonal transport in EAE mice at ON onset. In addition to morphological changes,
functional deficits, such as axonal transport disruption, also occurred at this stage. Preventing the worsening or curing the early axonal transport deficit may be a potential
treatment target to halt the degeneration of axons in MS. Our results showed the first quantitative assessment of axonal transport in EAE mice suggesting that MRMRI is
suitable for pre-clinical drug tests.
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